
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5341B88AF3DEF30541B8000B8B760D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="npgopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373499/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Nature Metabolism">
<meta name="citation_title" content="Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain">
<meta name="citation_author" content="Anne de Bray">
<meta name="citation_author_institution" content="Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Anna G Roberts">
<meta name="citation_author_institution" content="Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK">
<meta name="citation_author" content="Sarah Armour">
<meta name="citation_author_institution" content="Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Jason Tong">
<meta name="citation_author_institution" content="Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Christiane Huhn">
<meta name="citation_author_institution" content="Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany">
<meta name="citation_author" content="Blaise Gatin-Fraudet">
<meta name="citation_author_institution" content="Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany">
<meta name="citation_author" content="Kilian Roßmann">
<meta name="citation_author_institution" content="Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany">
<meta name="citation_author" content="Ali H Shilleh">
<meta name="citation_author_institution" content="Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Wanqing Jiang">
<meta name="citation_author_institution" content="Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK">
<meta name="citation_author" content="Natalie S Figueredo Burgos">
<meta name="citation_author_institution" content="Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK">
<meta name="citation_author" content="James P P Trott">
<meta name="citation_author_institution" content="Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK">
<meta name="citation_author" content="Katrina Viloria">
<meta name="citation_author_institution" content="Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Daniela Nasteska">
<meta name="citation_author_institution" content="Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Abigail Pearce">
<meta name="citation_author_institution" content="Department of Pharmacology, University of Cambridge, Cambridge, UK">
<meta name="citation_author" content="Satsuki Miyazaki">
<meta name="citation_author_institution" content="Division of Stem Cell Regulation Research, Center for Medical Research and Education, Osaka University Graduate School of Medicine, Suita, Osaka, Japan">
<meta name="citation_author" content="Jeremy W Tomlinson">
<meta name="citation_author_institution" content="Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Dylan M Owen">
<meta name="citation_author_institution" content="Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="School of Mathematics, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Daniel J Nieves">
<meta name="citation_author_institution" content="Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Julia Ast">
<meta name="citation_author_institution" content="Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK">
<meta name="citation_author" content="Malgorzata Cyranka">
<meta name="citation_author_institution" content="Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK">
<meta name="citation_author" content="Alexey Epanchintsev">
<meta name="citation_author_institution" content="Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK">
<meta name="citation_author" content="Carina Ämmälä">
<meta name="citation_author_institution" content="Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK">
<meta name="citation_author" content="Frank Reimann">
<meta name="citation_author_institution" content="Institute of Metabolic Science-Metabolic Research Laboratories &amp; MRC-Metabolic Diseases Unit, University of Cambridge, Cambridge, UK">
<meta name="citation_author" content="Tolga Soykan">
<meta name="citation_author_institution" content="Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany">
<meta name="citation_author" content="Graham Ladds">
<meta name="citation_author_institution" content="Department of Pharmacology, University of Cambridge, Cambridge, UK">
<meta name="citation_author" content="Alice E Adriaenssens">
<meta name="citation_author_institution" content="Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK">
<meta name="citation_author" content="Stefan Trapp">
<meta name="citation_author_institution" content="Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK">
<meta name="citation_author" content="Ben Jones">
<meta name="citation_author_institution" content="Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK">
<meta name="citation_author" content="Johannes Broichhagen">
<meta name="citation_author_institution" content="Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany">
<meta name="citation_author" content="David J Hodson">
<meta name="citation_author_institution" content="Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="7">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="1536">
<meta name="citation_doi" content="10.1038/s42255-025-01342-6">
<meta name="citation_pmid" content="40830598">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373499/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373499/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373499/pdf/42255_2025_Article_1342.pdf">
<meta name="description" content="Dual agonists targeting glucagon-like peptide-1 receptor (GLP1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) are breakthrough treatments for patients with type 2 diabetes and obesity. Compared to GLP1R agonists, dual agonists ...">
<meta name="og:title" content="Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Dual agonists targeting glucagon-like peptide-1 receptor (GLP1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) are breakthrough treatments for patients with type 2 diabetes and obesity. Compared to GLP1R agonists, dual agonists ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373499/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373499">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s42255-025-01342-6"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/42255_2025_Article_1342.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373499%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373499/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373499/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373499/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-npgopen.png" alt="Nature Portfolio logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Nature Portfolio" title="Link to Nature Portfolio" shape="default" href="https://doi.org/10.1038/s42255-025-01342-6" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Nat Metab</button></div>. 2025 Aug 19;7(8):1536–1549. doi: <a href="https://doi.org/10.1038/s42255-025-01342-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s42255-025-01342-6</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Nat%20Metab%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nat%20Metab%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Nat%20Metab%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Nat%20Metab%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Bray%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Anne de Bray</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Anne de Bray</span></h3>
<div class="p">
<sup>1</sup>Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div class="p">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Bray%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anne de Bray</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roberts%20AG%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Anna G Roberts</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Anna G Roberts</span></h3>
<div class="p">
<sup>3</sup>Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roberts%20AG%22%5BAuthor%5D" class="usa-link"><span class="name western">Anna G Roberts</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Armour%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Sarah Armour</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Sarah Armour</span></h3>
<div class="p">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Armour%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sarah Armour</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tong%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jason Tong</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jason Tong</span></h3>
<div class="p">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tong%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jason Tong</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huhn%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Christiane Huhn</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Christiane Huhn</span></h3>
<div class="p">
<sup>4</sup>Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huhn%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christiane Huhn</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gatin-Fraudet%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Blaise Gatin-Fraudet</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Blaise Gatin-Fraudet</span></h3>
<div class="p">
<sup>4</sup>Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gatin-Fraudet%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Blaise Gatin-Fraudet</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ro%C3%9Fmann%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Kilian Roßmann</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Kilian Roßmann</span></h3>
<div class="p">
<sup>4</sup>Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ro%C3%9Fmann%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kilian Roßmann</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shilleh%20AH%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Ali H Shilleh</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Ali H Shilleh</span></h3>
<div class="p">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shilleh%20AH%22%5BAuthor%5D" class="usa-link"><span class="name western">Ali H Shilleh</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Wanqing Jiang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Wanqing Jiang</span></h3>
<div class="p">
<sup>3</sup>Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wanqing Jiang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Figueredo%20Burgos%20NS%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Natalie S Figueredo Burgos</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Natalie S Figueredo Burgos</span></h3>
<div class="p">
<sup>3</sup>Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Figueredo%20Burgos%20NS%22%5BAuthor%5D" class="usa-link"><span class="name western">Natalie S Figueredo Burgos</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Trott%20JPP%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">James P P Trott</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">James P P Trott</span></h3>
<div class="p">
<sup>3</sup>Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Trott%20JPP%22%5BAuthor%5D" class="usa-link"><span class="name western">James P P Trott</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Viloria%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Katrina Viloria</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Katrina Viloria</span></h3>
<div class="p">
<sup>1</sup>Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div class="p">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Viloria%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Katrina Viloria</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nasteska%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Daniela Nasteska</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Daniela Nasteska</span></h3>
<div class="p">
<sup>1</sup>Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div class="p">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nasteska%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniela Nasteska</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pearce%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Abigail Pearce</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Abigail Pearce</span></h3>
<div class="p">
<sup>5</sup>Department of Pharmacology, University of Cambridge, Cambridge, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pearce%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Abigail Pearce</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miyazaki%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Satsuki Miyazaki</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Satsuki Miyazaki</span></h3>
<div class="p">
<sup>6</sup>Division of Stem Cell Regulation Research, Center for Medical Research and Education, Osaka University Graduate School of Medicine, Suita, Osaka, Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miyazaki%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Satsuki Miyazaki</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tomlinson%20JW%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Jeremy W Tomlinson</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Jeremy W Tomlinson</span></h3>
<div class="p">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tomlinson%20JW%22%5BAuthor%5D" class="usa-link"><span class="name western">Jeremy W Tomlinson</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Owen%20DM%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Dylan M Owen</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Dylan M Owen</span></h3>
<div class="p">
<sup>7</sup>Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div class="p">
<sup>8</sup>Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham, UK </div>
<div class="p">
<sup>9</sup>School of Mathematics, University of Birmingham, Birmingham, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Owen%20DM%22%5BAuthor%5D" class="usa-link"><span class="name western">Dylan M Owen</span></a>
</div>
</div>
<sup>7,</sup><sup>8,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nieves%20DJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Daniel J Nieves</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Daniel J Nieves</span></h3>
<div class="p">
<sup>7</sup>Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div class="p">
<sup>8</sup>Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nieves%20DJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniel J Nieves</span></a>
</div>
</div>
<sup>7,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ast%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Julia Ast</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Julia Ast</span></h3>
<div class="p">
<sup>1</sup>Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div class="p">
<sup>10</sup>Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ast%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julia Ast</span></a>
</div>
</div>
<sup>1,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cyranka%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Malgorzata Cyranka</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Malgorzata Cyranka</span></h3>
<div class="p">
<sup>10</sup>Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cyranka%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Malgorzata Cyranka</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Epanchintsev%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Alexey Epanchintsev</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Alexey Epanchintsev</span></h3>
<div class="p">
<sup>10</sup>Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Epanchintsev%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexey Epanchintsev</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22%C3%84mm%C3%A4l%C3%A4%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Carina Ämmälä</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Carina Ämmälä</span></h3>
<div class="p">
<sup>10</sup>Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22%C3%84mm%C3%A4l%C3%A4%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carina Ämmälä</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reimann%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Frank Reimann</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Frank Reimann</span></h3>
<div class="p">
<sup>11</sup>Institute of Metabolic Science-Metabolic Research Laboratories &amp; MRC-Metabolic Diseases Unit, University of Cambridge, Cambridge, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reimann%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Frank Reimann</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soykan%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Tolga Soykan</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Tolga Soykan</span></h3>
<div class="p">
<sup>4</sup>Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soykan%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tolga Soykan</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ladds%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Graham Ladds</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Graham Ladds</span></h3>
<div class="p">
<sup>5</sup>Department of Pharmacology, University of Cambridge, Cambridge, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ladds%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Graham Ladds</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adriaenssens%20AE%22%5BAuthor%5D" class="usa-link" aria-describedby="id26"><span class="name western">Alice E Adriaenssens</span></a><div hidden="hidden" id="id26">
<h3><span class="name western">Alice E Adriaenssens</span></h3>
<div class="p">
<sup>3</sup>Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adriaenssens%20AE%22%5BAuthor%5D" class="usa-link"><span class="name western">Alice E Adriaenssens</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Trapp%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id27"><span class="name western">Stefan Trapp</span></a><div hidden="hidden" id="id27">
<h3><span class="name western">Stefan Trapp</span></h3>
<div class="p">
<sup>3</sup>Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Trapp%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stefan Trapp</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jones%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id28"><span class="name western">Ben Jones</span></a><div hidden="hidden" id="id28">
<h3><span class="name western">Ben Jones</span></h3>
<div class="p">
<sup>12</sup>Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jones%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Ben Jones</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Broichhagen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id29"><span class="name western">Johannes Broichhagen</span></a><div hidden="hidden" id="id29">
<h3><span class="name western">Johannes Broichhagen</span></h3>
<div class="p">
<sup>4</sup>Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Broichhagen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Johannes Broichhagen</span></a>
</div>
</div>
<sup>4,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hodson%20DJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id30"><span class="name western">David J Hodson</span></a><div hidden="hidden" id="id30">
<h3><span class="name western">David J Hodson</span></h3>
<div class="p">
<sup>1</sup>Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div class="p">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hodson%20DJ%22%5BAuthor%5D" class="usa-link"><span class="name western">David J Hodson</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div id="Aff2">
<sup>2</sup>Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, UK </div>
<div id="Aff3">
<sup>3</sup>Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology &amp; Pharmacology, UCL, London, UK </div>
<div id="Aff4">
<sup>4</sup>Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany </div>
<div id="Aff5">
<sup>5</sup>Department of Pharmacology, University of Cambridge, Cambridge, UK </div>
<div id="Aff6">
<sup>6</sup>Division of Stem Cell Regulation Research, Center for Medical Research and Education, Osaka University Graduate School of Medicine, Suita, Osaka, Japan </div>
<div id="Aff7">
<sup>7</sup>Department of Immunology and Immunotherapy, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK </div>
<div id="Aff8">
<sup>8</sup>Centre of Membrane Proteins and Receptors, University of Birmingham, Birmingham, UK </div>
<div id="Aff9">
<sup>9</sup>School of Mathematics, University of Birmingham, Birmingham, UK </div>
<div id="Aff10">
<sup>10</sup>Novo Nordisk Research Centre Oxford, Innovation Building, Oxford, UK </div>
<div id="Aff11">
<sup>11</sup>Institute of Metabolic Science-Metabolic Research Laboratories &amp; MRC-Metabolic Diseases Unit, University of Cambridge, Cambridge, UK </div>
<div id="Aff12">
<sup>12</sup>Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Jul 31; Accepted 2025 Jun 24; Issue date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373499  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830598/" class="usa-link">40830598</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Dual agonists targeting glucagon-like peptide-1 receptor (GLP1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) are breakthrough treatments for patients with type 2 diabetes and obesity. Compared to GLP1R agonists, dual agonists show superior efficacy for glucose lowering and weight reduction. However, delineation of dual agonist cell targets remains challenging. Here, we develop and test daLUXendin and daLUXendin+, non-lipidated and lipidated fluorescent GLP1R/GIPR dual agonist probes, and use them to visualize cellular targets. daLUXendins are potent GLP1R/GIPR dual agonists that advantageously show less functional selectivity for mouse GLP1R over mouse GIPR. daLUXendins label rodent and human pancreatic islet cells, with a signal intensity of β cells &gt; α cells = δ cells. Systemic administration of daLUXendin strongly labels GLP1R<sup>+</sup> and GIPR<sup>+</sup> neurons in circumventricular organs characterized by an incomplete blood–brain barrier but does not penetrate the brain beyond labelling seen with single (ant)agonists. At the single-molecule level, daLUXendin targets endogenous GLP1R–GIPR nanodomains, which differ in organization and composition from those targeted by a single agonist. daLUXendins reveal dual agonist targets in the pancreas and brain and exclude a role for brain penetration in determining the superior efficacy of dual agonists, shedding new light on different modes of action of dual agonists versus single agonists.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Type 2 diabetes, Obesity, Receptor pharmacology, Super-resolution microscopy</p></section></section><section class="abstract" id="Abs2"><hr class="headless">
<p id="Par2">A series of fluorescent probes is designed that act as dual agonists on both GLP1 and GIP receptors, and are used to image receptor binding activities in tissues and animals.</p></section><section id="Sec1"><h2 class="pmc_sec_title">Main</h2>
<p id="Par3">Glucagon-like peptide-1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP) potently amplify insulin secretion and influence satiety to reduce food intake<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. Stabilized GLP1R agonists were approved for the treatment of type 2 diabetes in 2008 (ref. <sup><a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>) and at higher doses for overweight and obesity in 2017 and 2018 (ref. <sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>). Less attention has been paid to the GIP axis, as multiple studies showed that either genetic ablation or pharmacological blockade of GIPR protects against body weight gain<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>, and that GIPR agonism has minimal effects on glycemia in patients with type 2 diabetes<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>, potentially owing to GIPR downregulation<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>. However, dual agonists such as tirzepatide combine elements of GLP1R and GIPR agonism, such that the full benefits of both hormone axes are realized<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>.</p>
<p id="Par4">Although the pharmacological mechanisms underlying dual GLP1R/GIPR agonist efficacy are well established<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>, less is known about the cellular substrates that underlie actions on pancreatic hormone secretion as well as food intake. GLP1R and GIPR are low-abundance cell surface proteins, and their instability in solution makes it difficult to raise antibodies against specific epitopes, rendering their immunohistochemical visualization challenging<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. Specific antibodies exist for GLP1R, but no reliable commercial antibody exists yet for the detection of GIPR in primary cells and tissues<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. Compared to antibodies, GLP1R-Cre and GIPR-Cre reporter mice are sensitive, but only identify cells that express(ed) GLP1R/GIPR transcripts<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup>. Finally, animals harbouring a self-labelling enzyme on the GLP1R amino terminus allow facile visualization using a range of fluorophores, although this model is restricted to rodents<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. No approach to date provides information on GLP1Rs and GIPRs specifically accessed or bound by a dual agonist.</p>
<p id="Par5">To circumvent these issues, we previously developed LUXendins and sGIPs<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>–<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>, which are specific probes against GLP1R and GIPR, respectively. Using these probes, we confirmed that GLP1R is largely a β cell-specific protein marker<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>, whereas GIPR is expressed in both β cells and α cells within the islet<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. However, we were unable to make any inferences about dual agonist binding sites within the islet and brain, as GLP1R and GIPR probes might target different receptor (sub)populations. Dual agonism might also influence GIPR/GLP1R localization, expression and access through effects in addition to those mediated by GLP1R and/or GIPR (ant)agonism alone; for example, release of paracrine mediators and functional selectivity<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>. Although fluorescent tirzepatide has been reported<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>, the probe was not pharmacologically validated for its specificity at GLP1R/GIPR.</p>
<section id="Sec2"><h3 class="pmc_sec_title">Design of daLUXendin544 and daLUXendin660</h3>
<p id="Par6">Structure–activity relationships and cryo-electron microscopy show that the binding affinity and efficacy of GLP1R agonists, GIPR agonists and dual agonists are determined by amino acids closer to the N-terminus<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>–<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup>. We thus reasoned that carboxy-terminal functionalization with a fluorophore would be well tolerated, especially because this end is not commonly resolved in structural interpretations. Given that tirzepatide possesses a C-terminal serine, we decided to generate an S39C mutant, allowing the late-stage addition of a fluorophore (Fig. <a href="#Fig1" class="usa-link">1a,b</a>). daLUXendin544 and daLUXendin660 were obtained using cysteine-maleimide ‘click’ chemistry to install Cy3 and Cy5 fluorophores, respectively, in yields of ~50%. <em>iso</em>-butyric amino acid was incorporated into the structure instead of alanine at position two to confer degradation resistance against DPP-IV<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup> (Fig. <a href="#Fig1" class="usa-link">1a,b</a>). Spectral properties, compound purity and compound characterization are shown in Supplementary Fig. <a href="#Sec37" class="usa-link">1</a> and Supplementary Note <a href="#MOESM1" class="usa-link">1</a>.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Development and characterization of daLUXendin544 and daLUXendin660.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/670554ec9b5e/42255_2025_1342_Fig1_HTML.jpg" loading="lazy" id="d33e758" height="1077" width="788" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong>,<strong>b</strong>, Tirzepatide, modified at the C-terminus with S39C to allow maleimide conjugation with either Cy3 or Cy5 (model obtained from cryo-electron microscopic structure of non-acyl tirzepatide bound to activated GLP1R in complex with G<sub>s</sub>) (PDB <a href="https://www.rcsb.org/structure/7VBI" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">7VBI</a>)<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. <strong>c</strong>, cAMP responses to GLP1, GIP, tirzepatide (TZP), daLUXendin544 (daLUX544) and daLUXendin660 (daLUX660) in AD293 cells expressing either hGLP1R, mGLP1R, hGIPR or mGIPR (<em>n</em> = 4 independent repeats). <strong>d</strong>,<strong>e</strong>, Binding affinity of daLUXendin660 against hGLP1R and hGIPR (<strong>d</strong>), with <em>K</em><sub>d</sub> values (<strong>e</strong>) in a separate bar graph (one-site fit specific binding) (<em>n</em> = 3 independent repeats). <strong>f</strong>,<strong>g</strong>, Competition binding for daLUXendin660 (<strong>f</strong>) and either Ex4-Cy5 or GIP-Cy5 (<strong>g</strong>) at hGLP1R and hGIPR versus GLP1 and GIP (one-site fit <em>K</em><sub>i</sub>) (<em>n</em> = 3 independent repeats). <strong>h</strong>, p<em>K</em><sub>i</sub> values for daLUXendin660, Ex4-Cy5 and GIP-Cy5 at hGLP1R and hGIPR versus GLP1 and GIP (<em>n</em> = 3 independent repeats). <strong>i</strong>, Mice were fasted 3 h before the onset of the dark phase. At dark onset, mice were injected subcutaneously with either vehicle, daLUXendin660 (daLUX; 10 nmol kg<sup>−1</sup>) or tirzepatide (10 nmol kg<sup>−1</sup>), and then food was returned. Graph showing cumulative food intake 12 h and 24 h post injection (<em>n</em> = 8 mice per investigated state) (repeated-measures two-way ANOVA with Šídák’s multiple comparisons test). <strong>j</strong>, Tirzepatide and daLUXendin660 similarly lower glucose in GLP1R<sup>WT/WT</sup> and GLP1R<sup>WT/KO</sup> mice during glucose tolerance testing (<em>n</em> = at least five mice per investigated state). <strong>k</strong>,<strong>l</strong>, Efficacy of tirzepatide and daLUXendin660 is reduced in GLP1R<sup>KO/KO</sup> mice (<strong>k</strong>), shown also by area under the curve (AUC) (<strong>l</strong>) (<em>n</em> = at least five mice per investigated state) (one-way ANOVA with two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli). <strong>m</strong>, mGLP1R:mGIPR selectivity is lower for daLUXendin660 versus tirzepatide (selectivity is calculated using the mean AUC ratio from at least five GLP1R<sup>WT/WT</sup> and five GLP1R<sup>KO/KO</sup> mice). Bar and line graphs show means; error bars, s.e.m. ***<em>P</em> &lt; 0.001. Exact <em>P</em> values are displayed on each graph.</p>
<p><a href="#MOESM4" class="usa-link">Source data</a></p></figcaption></figure></section><section id="Sec3"><h3 class="pmc_sec_title">Pharmacology of daLUXendin544 and daLUXendin660</h3>
<p id="Par7">AD293 cells transfected with either human GLP1R (hGLP1R), mouse GLP1R (mGLP1R), human GIPR (hGIPR) or mouse GIPR (mGIPR) were used to determine cAMP signalling potency of daLUXendin544 and daLUXendin660 versus unmodified (acylated) tirzepatide, GIP and GLP1. At both hGLP1R and mGLP1R, tirzepatide and its fluorescent analogues showed reduced potency compared to GLP1, with the potency rank order favouring daLUXendin660 &gt; tirzepatide &gt; daLUXendin544 (Fig. <a href="#Fig1" class="usa-link">1c</a>) (Extended Data Table <a href="#Tab1" class="usa-link">1</a>). As previously reported for tirzepatide<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>, there were species differences for GIPR signalling with each of the dual agonist ligands tested, with all showing a larger loss of potency at the mGIPR than at the hGIPR relative to native hGIP (Fig. <a href="#Fig1" class="usa-link">1c</a>) (Extended Data Table <a href="#Tab1" class="usa-link">1</a> and Supplementary Table <a href="#MOESM1" class="usa-link">1</a>). Of note, even though daLUXendin544 showed globally reduced potency compared to daLUXendin660, half-maximum effective concentration (EC<sub>50</sub>) ratios suggested that both ligands show similar GIPR:GLP1R selectivity of ~2:1 (that is, favouring GIPR) for human receptors and ~1:2 (that is, favouring GLP1R) for mouse receptors. By comparison, tirzepatide showed GIPR:GLP1R selectivity of ~3:1 for human receptors and ~1:8 for mouse receptors in our assays.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Extended Data Table 1.</h4>
<div class="caption p"><p>daLUXendin554 and daLUXendin660 cAMP pharmacology</p></div>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Tab1_ESM.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/8b37d3384036/42255_2025_1342_Tab1_ESM.jpg" loading="lazy" id="d33e2158" height="637" width="759" alt="graphic file with name 42255_2025_1342_Tab1_ESM.jpg"></a></p>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p95"><p><em>EC</em><sub>50</sub> values for GLP1, GIP, Tirzepatide (TZP), daLUX544 and daLUX660 against human GLP1R (hGLP1R), mouse GLP1R (mGLP1R), human GIPR (hGIPR) and mouse GIPR (mGIPR) (n = 4 independent repeats).</p></div></div></section><p id="Par8">daLUXendin660 showed nM binding affinity at both hGLP1R and hGIPR, although assessment of the daLUXendin544 dissociation constant (<em>K</em><sub>d</sub>) was precluded by interference with the BRET signal (Fig. <a href="#Fig1" class="usa-link">1d,e</a>) (Supplementary Table <a href="#MOESM1" class="usa-link">2</a>). Competition assays showed that binding affinity (p<em>K</em><sub>i</sub>) for hGLP1/hGLP1R and hGIP/hGIPR was similar when using daLUXendin660 as a probe compared to Ex4-Cy5 and GIP-Cy5, further confirming strong receptor binding (Fig. <a href="#Fig1" class="usa-link">1f–h</a>) (Supplementary Table <a href="#MOESM1" class="usa-link">3</a>).</p>
<p id="Par9">Therefore, based upon cAMP assays and binding affinity, daLUXendin544 and daLUXendin660 are potent GLP1R/GIPR dual agonists that advantageously show approximately fourfold less selectivity for mouse GLP1R over GIPR compared to tirzepatide.</p></section><section id="Sec4"><h3 class="pmc_sec_title">daLUXendin660 shows less selectivity for GLP1R:GIPR in vivo</h3>
<p id="Par10">To establish whether in vitro pharmacology is mirrored by in vivo efficacy, mice were dosed with either tirzepatide or daLUXendin660 at 10 nmol kg<sup>−1</sup> to maximally engage mGLP1R and mGIPR<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>,<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>. At this dose, daLUXendin660 and tirzepatide both reduced food intake during the dark phase and over a cumulative 24 h period. At 12 h and 24 h post injection, tirzepatide demonstrated ~40% greater efficacy in driving anorexia, presumably because of its acylation and plasma binding (Fig. <a href="#Fig1" class="usa-link">1i</a>). Likewise, both tirzepatide and daLUXendin660 exerted substantial glucose-lowering effects in Glp1r<sup>WT/WT</sup> and Glp1r<sup>WT/KO</sup> mice, with similar area under the curves (Fig. <a href="#Fig1" class="usa-link">1j–l</a>). Both ligands partially maintained their efficacy in Glp1r<sup>KO/KO</sup> mice, reflecting continued engagement of mGIPR at doses &gt;1–3 nmol kg<sup>−1</sup> (Fig. <a href="#Fig1" class="usa-link">1j–l</a>). However, Glp1r knockout was less effective in daLUXendin660-treated versus tirzepatide-treated mice, demonstrating increased mGIPR dependence for daLUXendin660, as expected from in vitro functional selectivity data (Fig. <a href="#Fig1" class="usa-link">1j–m</a>). Results should, however, be interpreted in light of increased mGIPR sensitivity or expression in Glp1r<sup>KO/KO</sup> mice<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. Together, these data confirm that daLUXendin660 and tirzepatide both lower blood glucose and reduce food intake.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Cell labelling with daLUXendin544 and daLUXendin660</h3>
<p id="Par11">In line with the cAMP results, daLUXendin544 led to concentration-dependent labelling of SNAP-hGIPR:AD293 cells, overlapping with cell-impermeable SBG-Oregon Green (OG) SNAP label (Extended Data Fig. <a href="#Fig5" class="usa-link">1a,b</a>)<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. The brightest labelling was detected at 50 nM–5 µM, corresponding to the cAMP max (Extended Data Fig. <a href="#Fig5" class="usa-link">1a,b</a>). The strongest and most specific membrane labelling, without evidence of altered cell morphology (Extended Data Fig. <a href="#Fig5" class="usa-link">1a–c</a>), was observed with 500 nM daLUXendin544; hence, this concentration was selected for experiments in cell lines and tissue. No labelling was observed in non-transfected AD293 cells (Extended Data Fig. <a href="#Fig5" class="usa-link">1d</a>). Both daLUXendin544 and daLUXendin660 showed colocalization with cells transfected with SNAP_GIPR and Halo_GLP1R, determined using orthogonal cell-impermeable SNAP (SBG-OG) and Halo (CA-Sulfo549 or CA-Sulfo646) labels<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup> (Extended Data Fig. <a href="#Fig5" class="usa-link">1e,f</a>). Therefore, daLUXendin544 and daLUXendin660 are highly specific dual agonist probes suitable for cell labelling.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Extended Data Fig. 1. Validation of daLUXendin544 and daLUXendin660 labelling in cellulo.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Fig5_ESM.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/6826f7f4ece6/42255_2025_1342_Fig5_ESM.jpg" loading="lazy" id="d33e2012" height="604" width="722" alt="Extended Data Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a, b)</strong> daLUXendin544 labels SNAP_hGIPR:AD293 cells in a concentration-dependent manner (SBG-OG; cell impermeable SNAP label), shown by representative images (<strong>a</strong>), and line graph (<strong>b</strong>) (n = at least 7 wells, 2 independent repeats). <strong>c)</strong> 500 nM daLUXendin544 brightly labels SNAP_hGIPR:AD293 cells without signs of impaired morphology (n = at least 7 wells, 2 independent repeats). <strong>d)</strong> daLUXendin544 and daLUXendin660 do not label non-transfected AD293 cells (n = at least 9 wells, at least 2 independent repeats). <strong>e)</strong> daLUXendin544 labels cells co-expressing hGIPR and hGLP1R bearing orthogonal SNAP- and Halo-tags, visualized using cell impermeable SBG-OG (GIPR) and CA-Sulfo646 (GLP1R) (n = 24 wells, 3 independent repeats). <strong>f)</strong> As for e), but daLUXendin660 (n = 19 wells, 3 independent repeats). Scale bar = 212.5 µm in a, scale bar = 33.7 µm in d-f.</p>
<p>
<a href="#MOESM7" class="usa-link">Source data</a>
</p></figcaption></figure></section><section id="Sec6"><h3 class="pmc_sec_title">daLUXendins label endogenous GIPR and GLP1R</h3>
<p id="Par12">MIN6-CB4 β cells were labelled with both daLUXendin660 and the specific GLP1R probe LUXendin551 (refs. <sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>). Demonstrating specificity for GLP1R, LUXendin551 signal colocalized with daLUXendin660 (Extended Data Fig. <a href="#Fig6" class="usa-link">2a</a>), probably owing to labelling of different GLP1R pools (see below). However, not all daLUXendin660 signal colocalized with LUXendin551, presumably owing to GIPR labelling, as well as increased GLP1R internalization (Extended Data Fig. <a href="#Fig6" class="usa-link">2a</a>). To investigate this possibility further, MIN6-CB4 β cells were incubated with daLUXendin660 and the specific GIPR probe sGIP549 (ref. <sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>) (Extended Data Fig. <a href="#Fig6" class="usa-link">2b</a>). Demonstrating specificity for GIPR, sGIP549 signal colocalized with daLUXendin660, whereas not all daLUXendin660 signal colocalized with sGIP549, corresponding to GLP1R labelling (Extended Data Fig. <a href="#Fig6" class="usa-link">2b</a>). Therefore, daLUXendin660 labels both endogenous GLP1R and GIPR in MIN6-CB4 β cells.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Extended Data Fig. 2. daLUXendin544 and daLUXendin660 specifically label endogenous GLP1R and GIPR.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Fig6_ESM.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/c1c59bc5e21a/42255_2025_1342_Fig6_ESM.jpg" loading="lazy" id="d33e2065" height="536" width="722" alt="Extended Data Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a)</strong> daLUXendin660 and LUXendin551 (LUX551; GLP1R probe) labelling co-localize in MIN6-CB4 beta cells, which endogenously express GLP1R (n = 16 images from 4 wells, 2 independent repeats). <strong>b)</strong> daLUXendin660 and sGIP549 (GIPR probe) co-localize in MIN6-CB4 beta cells, which endogenously express GIPR (n = 16 images from 4 wells, 2 independent repeats). <strong>c)</strong> daLUXendin544 labelling co-localizes with BG-Sulfo646 SNAP label in GLP1R<sup>SNAP/SNAP</sup> mouse islets (n = 24 islets from 5 mice). <strong>d, e)</strong> daLUXendin544 labels membrane and cytoplasmic (that is, internalized) GLP1R pools in GLP1R<sup>SNAP/SNAP</sup> mouse islets, labelled using the cell impermeable SNAP label, BG-Sulfo646, and shown using full width at half maximum (FWHM) (line placement used for FHWM calculation is shown) (n = at least 18 islets from at least 5 mice). <strong>f)</strong> daLUXendin544 engages distinct GLP1R/GIPR pools in α cells versus β cells, with more membrane labelling in β cells (arrows show membrane labelling) (n = 37 islets from 3 mice). <strong>g)</strong> daLUXendin544 and sGIP648 (GIPR) labelling co-localize in mouse islets (n = 37 islets from 3 mice). <strong>h)</strong> Analysis showing strong co-localization between daLUXendin544 and either GLP1R or GIPR, labelled using LUXendin645 (LUX645) and sGIP648, respectively (n = 43 islets from 2 mice). <strong>i, j)</strong> daLUXendin544 labelling is reduced in GLP1R<sup>KO/KO</sup> islets, and further reduced in GLP1R<sup>KO/KO</sup> islets + 1 µM GIP Aib2 (n = 37 islets from 2 mice) (Kruskal-Walllis test with two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli). Scale bar = 33.7 µm in a and b; scale bar = 53 µm in c, d, f, g and j. No changes are seen in vehicle-treated islets. Bar graphs show mean ± SEM. Exact <em>p</em> values are displayed on each graph.</p>
<p>
<a href="#MOESM8" class="usa-link">Source data</a>
</p></figcaption></figure><p id="Par13">We next repeated studies in isolated mouse islets. To circumvent competition between the various probes at GLP1R/GIPR, we used GLP1R<sup>SNAP/SNAP</sup> mice in which a SNAP-tag enzyme self-label is knocked into the extracellular domain of the endogenous GLP1R<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>, allowing GLP1R to be visualized without influencing orthosteric binding. Using this model, colocalization could be detected between the cell-impermeable SNAP label BG-Sulfo646 and daLUXendin544 (Extended Data Fig. <a href="#Fig6" class="usa-link">2c</a>). We noticed that daLUXendin544 retained significant levels of GLP1R at the cell surface, as shown by the full width at half maximum (Extended Data Fig. <a href="#Fig6" class="usa-link">2d,e</a>). By contrast, daLUXendin544 did not exhibit any detectable membrane labelling in α cells, presumably because they express little to no GLP1R transcript or protein (also used to identify α cells versus β cells) (Extended Data Fig. <a href="#Fig6" class="usa-link">2f,h</a>)<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>, so α cell labelling is largely by GIPR. Using the GIPR probe sGIP648, daLUXendin544 was found to strongly label GIPR in mouse islets (Extended Data Fig. <a href="#Fig6" class="usa-link">2g,h</a>), also apparent from studies with the GLP1R probes and GLP1R SNAP labels. Lastly, daLUXendin544 labelling was reduced ~50% in GLP1R<sup>KO/KO</sup> islets, with a further reduction in labelling seen in the presence of a saturating concentration of GIPAib2 (1 µM) (Extended Data Fig. <a href="#Fig6" class="usa-link">2i,j</a>).</p></section><section id="Sec7"><h3 class="pmc_sec_title">daLUXendins label most endocrine cell types within the islet</h3>
<p id="Par14">To allow post hoc protein labelling and identification of cell types in complex tissue, we optimized a fixation protocol that retained strong and specific daLUXendin544 and daLUXendin660 labelling post-fixation with either 2% or 4% formalin for 15 min (Fig. <a href="#Fig2" class="usa-link">2a</a>). Islets were labelled with daLUXendin544 before formalin-fixation, and immunostaining with antibodies against either insulin, glucagon or somatostatin to identify β cells, α cells or δ cells, respectively. As expected, given their abundant GLP1R and GIPR expression, β cells were strongly labelled with daLUXendin544 (Fig. <a href="#Fig2" class="usa-link">2b</a>). Confirming results in live islets, α cells showed weaker but detectable daLUXendin544 labelling restricted to the cytoplasm (Fig. <a href="#Fig2" class="usa-link">2c</a>), probably reflecting their abundant GIPR expression and largely absent GLP1R protein expression<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. δ cells also showed weaker labelling versus β cells (Fig. <a href="#Fig2" class="usa-link">2d</a>). However, labelling was observed both in the cytoplasm and membrane, which might reflect low-moderate expression of GIPR and GLP1R protein (Fig. <a href="#Fig2" class="usa-link">2d</a>). Identical results were obtained with daLUXendin660 (Fig. <a href="#Fig2" class="usa-link">2e</a>). Quantification of daLUXendin544/660 labelling is shown in Fig. <a href="#Fig2" class="usa-link">2f,g</a>. Demonstrating efficacy of daLUXendin660 in vivo, islets in GLP1R-tdRFP and GIPR-GFP reporter mice were strongly and specifically labelled 60 min following intravenous injection with 100 nmol kg<sup>−1</sup> probe but not vehicle (Fig. <a href="#Fig2" class="usa-link">2h,i</a>). As for isolated islets, both GLP1R<sup>+</sup> and GLP1R<sup>−</sup> cells were labelled in vivo, the latter probably representing GIPR<sup>+</sup> cells (that is, α cells) (Fig. <a href="#Fig2" class="usa-link">2h</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. daLUXendin544 and daLUXendin660 reveal dual agonist targets in primary and SC-islets.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/5b2b18f85489/42255_2025_1342_Fig2_HTML.jpg" loading="lazy" id="d33e1111" height="903" width="722" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong>, Following labelling of live islets, daLUXendin660 can be fixed using either 2% or 4% formalin (FA) for 15 min (<em>n</em> = at least five islets from three mice). <strong>b</strong>, daLUXendin544 labels insulin-positive (INS<sup>+</sup>) cells throughout the mouse islet (<em>n</em> = 44 islets from five mice). <strong>c</strong>,<strong>d</strong>, daLUXendin544 labels glucagon-positive (GCG<sup>+</sup>) and somatostatin-positive (SST<sup>+</sup>) cells throughout the islet, although to a lesser extent than INS<sup>+</sup> cells (INS, 44 islets from five mice; GCG, 25 islets from seven mice; SST, 29 islets from seven mice). <strong>e</strong>, daLUXendin660 displays a similar labelling pattern to daLUXendin544 in mouse islets (INS, 43 islets from five mice; GCG, 30 islets from seven mice; SST, 27 islets from seven mice). <strong>f</strong>,<strong>g</strong>, Quantification of daLUXendin544 (<strong>f</strong>) and daLUXendin660 (<strong>g</strong>) labelling intensity in INS<sup>+</sup>, GCG<sup>+</sup> and SST<sup>+</sup> cell populations (Kruskal–Wallis test with Dunn’s multiple comparisons test). CTCF, corrected total cell fluorescence. <strong>h</strong>, Intravenous (i.v.) injection of daLUXendin660, but not vehicle (inset), labels GLP1R<sup>+</sup> cells in islets from GLP1R-tdRFP reporter mice (arrows show GLP1R<sup>−</sup> but daLUXendin660+ cells) (<em>n</em> = at least nine islets). <strong>i</strong>, As in <strong>h</strong>, but with GIPR-GFP reporter mice (<em>n</em> = 9 islets). <strong>j</strong>, Uniform manifold approximation and projection (UMAP) plots showing <em>GLP1R</em> and <em>GIPR</em> expression in early and late SC-islet endocrine cell populations (taken from a previous publication<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>, and plotted using Single Cell Portal<sup><a href="#CR54" class="usa-link" aria-describedby="CR54">54</a></sup>, study SCP1526). <strong>k</strong>,<strong>l</strong>, daLUXendin660 labels INS<sup>+</sup>, GCG<sup>+</sup> and SST<sup>+</sup> cell populations in SC-islets (inset in <strong>k</strong>, a separate non-immunostained SC-islet showing membrane and cytoplasmic daLUXendin660 signal). Scale bar, 53 µm. Violin plots show min–max and median. Exact <em>P</em> values are displayed on each graph.</p>
<p><a href="#MOESM5" class="usa-link">Source data</a></p></figcaption></figure></section><section id="Sec8"><h3 class="pmc_sec_title">daLUXendins label most cell types in human stem cell islets</h3>
<p id="Par15">Fluorescent labelling of low-abundance proteins in human islets is limited by high levels of autofluorescence, in particular from lipofuscin accumulation<sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>. In addition, human islet preparations display heterogeneity in response to GLP1R/GIPR agonist, probably reflecting variable GLP1R/GIPR expression as well as time in culture. To circumvent these issues, we instead turned to human induced pluripotent stem (iPS) cell-derived islet-like structures (SC-islets), which are therapeutically important as a cell therapy for type 1 diabetes<sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>,<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>. Analysis of published single-cell RNA sequencing data<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup> revealed <em>GIPR</em> and <em>GLP1R</em> in early and late β-like cells as well as δ cells, and <em>GIPR</em> in early and late α cells (Fig. <a href="#Fig2" class="usa-link">2j</a>). daLUXendin660 labelling was qualitatively similar to that observed in mouse islets, with cells displaying two similar labelling patterns: membrane labelling + cytoplasmic labelling or cytoplasmic staining alone (Fig. <a href="#Fig2" class="usa-link">2k</a>, inset). In keeping with the transcriptomic data, immunostaining revealed daLUXendin660 labelling in insulin (INS<sup>+</sup>), glucagon (GCG<sup>+</sup>) and somatostatin (SST<sup>+</sup>) cell populations (Fig. <a href="#Fig2" class="usa-link">2j–l</a>). Some daLUXendin660 labelling was detected in INS<sup>−</sup>/GCG<sup>−</sup>/SST<sup>−</sup> cells, which were presumably GLP1R/GIPR-expressing enteroendocrine cells that are present in most differentiations (Fig. <a href="#Fig2" class="usa-link">2j–l</a>). Similar to mouse islets, the strongest daLUXendin660 labelling was seen in β cells, with weaker but detectable labelling in α cells and δ cells (Fig. <a href="#Fig2" class="usa-link">2k,l</a>) (corrected total cell fluorescence, 3.60 × 10<sup>5</sup> ± 2.58 × 10<sup>5</sup> versus 2.30 × 10<sup>5</sup> ± 1.59 × 10<sup>5</sup> versus 2.16 × 10<sup>5</sup> ± 1.46 × 10<sup>5</sup> AU, β cells versus α cells versus δ cells, respectively; <em>P</em> &lt; 0.0005 one-way ANOVA and Šídák’s multiple comparisons test) (<em>n</em> = 12 SC-islets from two differentiations).</p></section><section id="Sec9"><h3 class="pmc_sec_title">daLUXendin660+ optimized for long-term dosing</h3>
<p id="Par16">To expand the utility of daLUXendin660 for long-term dosing, we installed a C20 di-acid lipid chain on lysine at position 20 to confer albumin binding. The new molecule, termed daLUXendin660+, performed similarly to daLUXendin660 in pharmacology and receptor binding assays, demonstrating that acylation and lipid modification is well tolerated (Extended Data Fig. <a href="#Fig7" class="usa-link">3a–d</a>) (Extended Data Table <a href="#Tab2" class="usa-link">2</a> and Supplementary Table <a href="#MOESM1" class="usa-link">4</a>). No differences in pancreatic islet cell labelling could be detected between daLUXendin660 and daLUXendin660+ applied to the same islet batch (that is, INS &gt; GCG and SST) (Extended Data Fig. <a href="#Fig7" class="usa-link">3e–h</a>).</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Extended Data Fig. 3. Development and characterization of lipidated daLUXendin660+.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Fig7_ESM.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/7df3a529fd3a/42255_2025_1342_Fig7_ESM.jpg" loading="lazy" id="d33e2115" height="906" width="682" alt="Extended Data Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a)</strong> daLUXendin660 can be further modified to generate daLUXendin660+ by installing a C20 di-acid lipid chain at lysine position 20. <strong>b)</strong> cAMP responses to daLUXendin660 (daLUX660) and daLUXendin660+ (daLUX660+) in AD293 cells expressing either human (h)GLP1R, mouse (m)GLP1R, human (h)GIPR or mouse (m)GIPR (n = 4 independent repeats). <strong>c, d)</strong> Binding affinity of daLUXendin660+ against hGLP1R and hGIPR (<strong>c</strong>), with Kd values (<strong>d</strong>) in a separate bar graph (one-site fit specific binding) (n = 3 independent repeats). <strong>e-h)</strong> daLUX660+ labels islets similarly to daLUX660, with strength of labelling β cells &gt; α cells = δ cells, as shown by representative images (<strong>e</strong>, <strong>g</strong>) and summary bar graphs (<strong>f</strong>, <strong>h</strong>) (INS, insulin = at least 26 islets from 5 mice; GCG, glucagon = at least 16 islets from 5 mice; SST, somatostatin = at least 16 islets from 5 mice) (Kruskal-Wallis test with Dunn’s multiple comparisons test). Scale bar = 53 µm. Scatter plots and line graphs show mean ± SEM. Violin plots shows min-max and median. Exact <em>p</em> values are displayed on each graph.</p>
<p>
<a href="#MOESM9" class="usa-link">Source data</a>
</p></figcaption></figure><section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Extended Data Table 2.</h4>
<div class="caption p"><p>daLUXendin660 and daLUXendin660+ pharmacology</p></div>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Tab2_ESM.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/3048200f072e/42255_2025_1342_Tab2_ESM.jpg" loading="lazy" id="d33e2177" height="229" width="759" alt="graphic file with name 42255_2025_1342_Tab2_ESM.jpg"></a></p>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p98"><p>cAMP <em>EC</em><sub>50</sub> values for daLUX660 and daLUX660+ against human GLP1R (hGLP1R), mouse GLP1R (mGLP1R), human GIPR (hGIPR) and mouse GIPR (mGIPR) (n = 4 independent repeats).</p></div></div></section></section><section id="Sec10"><h3 class="pmc_sec_title">daLUXendins label GLP1R<sup>+</sup> and GIPR<sup>+</sup> neurons</h3>
<p id="Par17">Following intravenous injection (100 nmol kg<sup>−1</sup>), daLUXendin660 signal could be readily detected in the circumventricular organs and choroid plexus but not in other areas of the brain (Fig. <a href="#Fig3" class="usa-link">3a</a>). The circumventricular organs are characterized by an incomplete blood–brain barrier and include areas such as the median eminence, area postrema, subfornical organ and organum vasculosum of the lamina terminalis, brain regions known to bind GLP1R and GIPR (ant)agonists<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>. We did not observe any difference in the extent of brain penetration between daLUXendin660, daLUXendin660+ and the single GLP1R agonist LUXendin645 (Fig. <a href="#Fig3" class="usa-link">3a–c</a>). To establish which incretin receptor-expressing neurons are labelled with daLUXendin660, we performed intravenous injection (100 nmol kg<sup>−1</sup>) of daLUXendin660 in transgenic mice Cre-dependently expressing fluorescent reporters in either GLP1R-expressing cells (GLP1R-tdRFP) or GIPR-expressing cells (GIPR-GCaMP6). Clear colocalization of daLUXendin660 with GLP1R (Fig. <a href="#Fig3" class="usa-link">3d</a>) and GIPR (Fig. <a href="#Fig3" class="usa-link">3e</a>) neurons was observed in the area postrema.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. daLUXendin660 accesses circumventricular organs from the periphery.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/2deaa4d0c5b6/42255_2025_1342_Fig3_HTML.jpg" loading="lazy" id="d33e1308" height="696" width="730" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong>–<strong>c</strong>, Intravenous administration of 100 nmol kg<sup>−1</sup> daLUXendin660 (<em>n</em> = 3 mice) (<strong>a</strong>), 100 nmol kg<sup>−1</sup> daLUXendin660+ (<em>n</em> = 2 mice) (<strong>b</strong>) and subcutaneous administration of 100 nmol kg<sup>−1</sup> LUXendin645 (GLP1R antagonist) (<em>n</em> = 5 mice) (<strong>c</strong>) led to staining in circumventricular organs of the brain and the choroid plexus. Shown are the organum vasculosum of the lamina terminalis (i), subfornical organ (ii), choroid plexus (iii), median eminence (iv) and area postrema (v). <strong>d</strong>,<strong>e</strong>, Intravenous administration of 100 nmol kg<sup>−1</sup> daLUXendin660 in a GLP1R-tdRFP mouse (<em>n</em> = 1) (<strong>d</strong>) or GIPR-GCaMP6 mouse (<em>n</em> = 2) (<strong>e</strong>) labels GLP1R-expressing and GIPR-expressing cells, respectively (indicated by white arrows). Shown are the subfornical organ (i), median eminence (ii), area postrema (iii) and zoom-in of area postrema with merged (iii’), GLP1R-tdRFP/GIPR-GCaMP6 (iii’’) and daLUXendin660 (iii’’’) signals. Note that images in <strong>e</strong> are from the same mouse as in <strong>a</strong> but with GIPR-GCaMP6 signal overlaid. Scale bars, 100 µm.</p>
<p><a href="#Sec38" class="usa-link">Source data</a></p></figcaption></figure><p id="Par18">The strength and extent of labelling does not necessarily equate to agonist efficacy, especially for peptidic ligands that diffuse freely through fenestrated vessels of the median eminence into the ventricular system<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>,<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>. To assess the accessibility of daLUXendin660 binding sites from the cerebrospinal fluid, we performed intracerebroventricular injection of the probe. Intracerebroventricular administration of daLUXendin660 demonstrated clear penetration from the cerebrospinal fluid into the brain parenchyma. Strong labelling was observed in tanycytes—identified through vimentin immunostaining—within the third ventricle (Extended Data Fig. <a href="#Fig8" class="usa-link">4a</a>). daLUXendin660 labelling in tanycytes was localized to the apical surface as well as cellular processes extending into the brain parenchyma (Extended Data Fig. <a href="#Fig8" class="usa-link">4b</a>). Neurons identified as GLP1R<sup>+</sup> in GLP1R-tdRFP reporter mice were co-labelled with daLUXendin660 in the vicinity of the ventricles (Extended Data Fig. <a href="#Fig8" class="usa-link">4c</a>). Modest colocalization in GIPR<sup>+</sup> neurons was evident in GIPR-GCaMP6 reporter mice (Extended Data Fig. <a href="#Fig8" class="usa-link">4d</a>). A small number of neurons positive for both GIPR and GLP1R were labelled with daLUXendin660 (Extended Data Fig. <a href="#Fig8" class="usa-link">4e</a>).</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Extended Data Fig. 4. ICV-injected daLUXendin660 accesses the brain parenchyma and labels tanycytes.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Fig8_ESM.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/cc9deca46012/42255_2025_1342_Fig8_ESM.jpg" loading="lazy" id="d33e2148" height="1086" width="688" alt="Extended Data Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong>) Intracerebroventricular (icv) injection of daLUXendin660 (3.3–5 nmol/kg BW) labels cells surrounding the 3rd ventricle. daLUXendin660 colocalizes with tanycytes (indicated by vimentin immunolabeling) following icv administration (n = 4 mice). <strong>b</strong>) 3D-rendering showing extensive colocalization of daLUXendin660 with vimentin in tanycytes surrounding the 3rd ventricle (box labelled with i indicates region of magnified image). Labelling of GLP1R- and GIPR-expressing cells (examples indicated by arrows) was characterized in <strong>c</strong>) GLP1R-tdRFP (n = 2) and <strong>d</strong>) GIPR-GCaMP6 (n = 2) mice. Boxes labelled with i and ii indicate region of magnified images, with ’, ’’ and ’’’ representing merged, GLP1R/GIPR and daLUXendin660 signals, respectively. <strong>e</strong>) A small number of cells positive for both GIPR and <em>Glp1r</em> are labelled with daLUXendin660 following icv administration (indicated by arrow heads). Box labelled with i indicates region of magnified image, with ’, ’’ and ’’’ representing <em>Glp1r</em>, GIPR and daLUXendin660 signals, respectively. Scale bar = 100 µm.</p></figcaption></figure></section><section id="Sec11"><h3 class="pmc_sec_title">daLUXendin660 engages highly ordered GLP1R/GIPR nanodomains</h3>
<p id="Par19">GPCRs possess higher organization at the cell membrane and within the cell, forming nanodomains that are important for signalling<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>,<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>. We therefore set out to determine how endogenous GLP1R/GIPR nanodomains might be targeted by single agonists versus a dual agonist in primary tissue; that is, pancreatic islets. We first established nanodomain organization in the non-stimulated but bound state using LUXendin645, a GLP1R antagonist coupled to Cy5. Following 60 min incubation with LUXendin645, fixation and dSTORM nanoscopy of whole islets, we confirmed our previous data showing that non-stimulated GLP1R form discrete nanodomains<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup> (Fig. <a href="#Fig4" class="usa-link">4a,b</a>). The GIPR agonist sGIP648 also labelled discrete receptor nanodomains (GIPR), as defined by clustering (Fig. <a href="#Fig4" class="usa-link">4b–d</a>). daLUXendin660, however, engaged more ordered receptor nanodomains compared to the GIPR agonist alone, with high levels of clustering probably reflecting increased receptor interactions (Fig. <a href="#Fig4" class="usa-link">4b–d</a>). Localization number per cluster, as well as the density of each cluster, were similar across all ligands examined (Fig. <a href="#Fig4" class="usa-link">4e,f</a>). Together, these data suggest that tirzepatide either engages GLP1R into clustering or increases interactions between GLP1R and GIPR, thus contributing to its unique nanodomain arrangement. Owing to the long acquisition times needed for localization counting, dSTORM is best suited to fixed tissue. We therefore set out to show the applicability of daLUXendin660 for TIRF-based GLP1R/GIPR single particle tracking at the cell membrane in live MIN6-CB4 cells (Fig. <a href="#Fig4" class="usa-link">4g</a>). To open up super-resolution live imaging approaches, such as STED, we replaced the C-terminal Cy5 with fluorogenic deuterated silicon rhodamine (SiR-d12)<sup><a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup> to create daLUXendin651-d12 (Fig. <a href="#Fig4" class="usa-link">4h,i</a> and Supplementary Fig. <a href="#MOESM1" class="usa-link">1</a>). Labelling with daLUXendin651-d12 was too dim to visualize endogenous receptor but was sufficient to map GLP1R in fixed CHO-K1:SNAP-GLP1R:Halo-GIPR cells. daLUXendin651-d12 was able to image GLP1R below the diffraction limit and could be recorded over multiple frames (Supplementary Fig. <a href="#MOESM1" class="usa-link">2</a>). Following direct application of daLUXendin651-d12 to CHO-K1:SNAP-GLP1R:Halo-GIPR cells, far-red cell surface signal from SiR-d12 became rapidly visible (10 s) in live STED on the cell surface, colocalizing with BG-Sulfo549 and CA-AF488 (Fig. <a href="#Fig4" class="usa-link">4j</a>).</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. Dual agonist engages distinct endogenous GLP1R/GIPR nanodomains.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373499_42255_2025_1342_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/12373499/4a66c1552409/42255_2025_1342_Fig4_HTML.jpg" loading="lazy" id="d33e1476" height="1083" width="667" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong>, Schematic showing single-molecule labelling and localization strategy for GLP1R (LUXendin645; LUX645), GIPR (sGIP648) and GLP1R/GIPR (daLUXendin660) (PDB <a href="https://www.rcsb.org/structure/7VBI" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">7VBI</a>)<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. <strong>b</strong>, Representative dSTORM images show different single-molecule densities and organization (30 nm) of LUX645-bound GLP1R, sGIP648-bound GIPR and daLUXendin660-bound GLP1R/GIPR across an islet cell population (nucleus is bounded by dashed line) (<em>n</em> = 5 islets from three mice). <strong>c</strong>,<strong>d</strong>, daLUXendin660 labels more GLP1R/GIPR clusters compared to either LUX645 or sGIP648, shown by representative images (<strong>c</strong>) and bar graph (<strong>d</strong>) (<em>n</em> = 5 islets from three mice) (one-way ANOVA with two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli). <strong>e</strong>, Distribution and mean (inset) localization per cluster are similar across LUX645, sGIP648 and daLUXendin660 probes (<em>n</em> = 5 islets from three mice) (one-way ANOVA with Šídák’s multiple comparisons test). <strong>f</strong>, As in <strong>e</strong>, but for cluster density (one-way ANOVA with Šídák’s multiple comparisons test). <strong>g</strong>, Single particle tracking of daLUXendin660-labelled GLP1R/GIPR, showing min–max displacement (<em>n</em> = 5 cells, two independent repeats). <strong>h</strong>,<strong>i</strong>, SiR-d12 can be installed on daLUXendin (<strong>h</strong>) to create daLUXendin651-d12 (<strong>i</strong>), optimized for STED nanoscopy. <strong>j</strong>, Confocal snapshots showing CHO-K1:SNAP-GLP1R:Halo-GIPR cells labelled for GLP1R (BG-Sulfo549) and GIPR (CA-AF488) before live STED imaging of daLUXendin651-d12 labelling (<em>n</em> = 5 wells). Scale bars are provided on each figure. ns, non-significant. Exact <em>P</em> values are displayed on each graph.</p>
<p><a href="#MOESM6" class="usa-link">Source data</a></p></figcaption></figure><p id="Par20">In the present study, we synthesize and validate daLUXendins, red and far-red GLP1R/GIPR dual agonist probes. Nanomolar concentrations of daLUXendin specifically label GLP1R/GIPR in live cells, allowing endogenous binding sites and cellular targets for dual agonists such as tirzepatide to be visualized and interrogated. daLUXendin labelling can be achieved in most cells and tissues with a simple 1 h incubation or injection, followed by washing and analysis. Advantageously, daLUXendins show minimal loss in signal intensity when formaldehyde-fixed, allowing co-labelling for other cellular or neuronal proteins and markers.</p>
<p id="Par21">A key aspect of tirzepatide efficacy is increased potency and selectivity at human GIPR compared to GLP1R, with approximately 70% of activity at GIPR<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>. In mice, however, tirzepatide is selective for GLP1R over GIPR, and its insulinotropic and overall therapeutic efficacy is equivalent or non-superior to semaglutide (GLP1R agonist)<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. Although this is unlikely to have any bearing on GLP1R and GIPR accessed and bound by tirzepatide, it remains a limitation to the use of preclinical mouse models to understand GLP1R/GIPR dual agonism. Notably, daLUXendin544 and daLUXendin660 displayed less selectivity for GLP1R over GIPR in mouse (1:2 GIPR:GLP1R) compared to tirzepatide (1:8 GIPR:GLP1R). Although the exact mechanisms underlying the differences between daLUXendin544/660 and tirzepatide remain unknown, our previous studies showed that fluorophore modification can increase GLP1R agonist efficacy<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>. Therefore, daLUXendin660 could be a useful tool for probing dual agonist biology in the mouse.</p>
<p id="Par22">Within the pancreatic islet, tirzepatide labelled β cells &gt; α cells = δ cells, in keeping with known protein or transcript expression levels for GLP1R and GIPR (as previously reviewed<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>). Although studies have shown that tirzepatide stimulates secretion of insulin, somatostatin and glucagon<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>,<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>, the cellular substrates have so far remained elusive. The observation that tirzepatide labels β cells, δ cells and α cells suggests both direct and paracrine modes of action. Given that α cells express GIPR &gt;&gt; GLP1R, direct effects of tirzepatide on glucagon secretion are probably mediated by GIPR signalling, a known stimulator of α cell function<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>,<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>. By contrast, δ cells express GIPR &gt; GLP1R, inferring a predominant role for GIPR in tirzepatide-stimulated somatostatin secretion, with some GLP1R contribution. β cells express GLP1R = GIPR, but increased affinity of tirzepatide for human GIPR<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup> is likely to disproportionately contribute to insulin secretion. As well as exerting direct effects on islet cell function, tirzepatide is also likely to stimulate α cell-to-β cell and δ cell-to-β cell communication, further regulating insulin release (as previously reviewed<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>,<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>). At the same time, tirzepatide might engage β cell-to-α cell or δ cell-to-α cell communication to provide a brake on glucagon secretion.</p>
<p id="Par23">Peripherally injected daLUXendin660 was able to label the pancreas as well as readily access the median eminence, organum vasculosum of the lamina terminalis, subfornical organ and area postrema. The extent of daLUXendin660 labelling was similar to that seen for a GLP1R antagonist, LUXendin645, as well as a GIPR agonist, sGIP648 (refs. <sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>). We therefore speculate that the superior efficacy of GLP1R/GIPR dual agonism versus single GLP1R agonism reflects the specific neuronal and supporting cell populations that are activated rather than the extent of brain access. When administered directly into the ventricular space of the brain, daLUXendin660 labelled GLP1R<sup>+</sup> and GIPR<sup>+</sup> neurons in the vicinity of the ventricles, as well as periventricular cells such as third ventricular tanycytes. Periventricular cell labelling is a common feature across GLP1R/GIPR (dual) (ant)agonists, pointing to a critical role for this cell type in the regulation of food intake and possibly the ligands themselves<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup>.</p>
<p id="Par24">Outside of conventional pharmacology, it remains unknown how daLUXendin660 interacts with GLP1R/GIPR in cells that endogenously express both receptors. Single-molecule localization microscopy showed that daLUXendin660 densely labelled GLP1R/GIPR clusters or nanodomains in islets, which was in addition to that seen with a GIPR agonist alone. Therefore, daLUXendin660 probably influences either GLP1R clustering or GLP1R and GIPR localization to increase nanodomain formation. We speculate that GIPR and GLP1R signalling within or between cell nanodomains, rather than simple signal summation across the cytoplasm, contributes to tirzepatide efficacy, as recently shown for GLP1 and β<sub>2</sub>-adrenergic receptors<sup><a href="#CR44" class="usa-link" aria-describedby="CR44">44</a></sup>.</p>
<p id="Par25">Tirzepatide is just one of many emerging dual and triple agonists that might exhibit different receptor engagement profiles. Given that we are still piecing together single agonist function<sup><a href="#CR45" class="usa-link" aria-describedby="CR45">45</a></sup>, daLUXendin provides a powerful tool to understand dual agonist receptor engagement, brain or organ access and receptor synergism. Owing to the structural similarities between dual and triple agonists, in the future, daLUXendins can be easily modified to incorporate a glucagon receptor agonist component.</p>
<p id="Par26">The study has a number of limitations. Firstly, tirzepatide and daLUXendins are different molecules, and detailed pharmacokinetic profiles were not determined. Therefore, we cannot categorically state that brain areas or cell types accessed by tirzepatide in humans and rodents would be similar to those accessed by daLUXendins in rodents. Secondly, we did not provide any data on human islets. We have noticed heterogeneity in GLP1R/GIPR expression, probably reflecting culture time and donor variability, compounded by high levels of lipofuscin autofluorescence<sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>. Thirdly, we restricted daLUXendin544/660/651-d12 to Cy3, Cy5 and SiR-d12 fluorophores, as they are well suited for complex tissue labelling<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. In the future, the daLUXendin colour palette could be extended to include blue-near-infrared and even epitope tags to allow signal amplification.</p>
<p id="Par27">In summary, daLUXendin544/660 are highly specific probes that highlight dual agonist target cells within complex tissues such as the pancreatic islet and brain. We envisage that daLUXendin544/660 will provide interrogable mechanisms underlying dual agonist efficacy.</p></section></section><section id="Sec12"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec13"><h3 class="pmc_sec_title">Study design</h3>
<p id="Par28">Individual data points are reported in the figures, and no data were excluded. Islet isolation is a nuisance variable, and as such, data are taken from independent islet preparations. To ensure that all states were represented in the different experiment arms, randomization was used to allocate samples and animals to treatment groups. All studies combined males and females, as no sex-specific phenotype has been reported for any of the genetically modified lines used, and male and female tissues were indistinguishable by their chemical probe or SNAP-tag labelling.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Ethics</h3>
<p id="Par29">Animal studies were regulated by the Animals (Scientific Procedures) Act 1986 of the UK (Personal Project Licences P2ABC3A83, PP1778740 and PP6526002). Approval was granted by the University of Birmingham, University of Oxford and University College London Animal Welfare and Ethical Review Bodies (AWERB).</p>
<p id="Par30">Studies with human iPS cells were reviewed by the University of Oxford Medical Sciences Interdivisional Research Ethics Committee (MS IDREC). The study utilizes iPS cells, which are created entirely outside the body and, as such, do not fall under the Governance of the Human Tissue Authority requiring ethics approval for their use in the United Kingdom.</p></section><section id="Sec15"><h3 class="pmc_sec_title">General chemistry</h3>
<p id="Par31">Chemicals and solvents were purchased from Merck, TCI (Tokyo Chemical Industry) and Acros Organics (Thermo Fisher Scientific) and used without further purification. Dry solvents were purchased from Acros Organics (Thermo Fisher Scientific). Amino acids and resins for solid-phase peptide synthesis were purchased from Novabiochem (Merck) or Iris Biotech.</p>
<p id="Par32">Ultra-high performance liquid chromatography with UV–visible light detection was performed for purity assessment, using an Agilent 1260 Infinity II LC System equipped with an Agilent SB-C18 column (1.8 µm, 2.1 × 50 mm). Buffer A consisted of 0.1% formic acid in H<sub>2</sub>O; buffer B consisted of 0.1% formic acid in acetonitrile. The typical gradient was from 10% B for 1.0 min → gradient to 95% B over 5 min → 95% B for 1.0 min with 0.45 ml min<sup>−1</sup> flow or from 30% B for 1.0 min → gradient to 95% B over 5 min. Retention times are given in minutes. Chromatograms were imported into Graphpad Prism 8, and purity was determined by calculating area under the curve ratios.</p>
<p id="Par33">Preparative or semi-preparative high-performance liquid chromatography was performed on an Agilent 1260 Infinity II LC System equipped with columns as follows: preparative column, Reprospher 100 C18 columns (10 μm: 50 × 30 mm at 20 ml min<sup>−1</sup> flow rate; semi-preparative column, 5 μm: 250 × 10 mm at 4 ml min<sup>−1</sup> flow rate. Eluents A (0.1% TFA in H2O) and B (0.1% TFA in MeCN) were applied as a linear gradient. Peak detection was performed at maximal absorbance wavelength.</p>
<p id="Par34">For high-resolution mass spectrometry, samples were analysed on an Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific). Mass spectrometry scans were acquired in a range of 350–1500 <em>m</em>/<em>z</em>. MS1 scans were acquired in the Orbitrap with a mass resolution of 120,000 with an AGC target value of 4 × 10<sup>5</sup> and 50 ms injection time. MS2 scans were acquired in the ion trap with an AGC target value of 1 × 10<sup>4</sup> and 35 ms injection time. Precursor ions with charge states two to four were isolated with an isolation window of 1.6 <em>m</em>/<em>z</em> and 40 s dynamic exclusion. Precursor ions were fragmented using higher-energy collisional dissociation with 30% normalized collision energy.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Peptide synthesis</h3>
<p id="Par35">Peptide synthesis and chemical characterization (high-resolution mass spectrometry, high-performance liquid chromatography) are detailed in the Supplementary Note <a href="#MOESM1" class="usa-link">1</a>.</p></section><section id="Sec17"><h3 class="pmc_sec_title">HTRF cAMP assay</h3>
<p id="Par36">AD293 cells (RRID:<a href="https://scicrunch.org/resolver/CVCL_9804/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CVCL_9804</a>) were transiently transfected 24 h before the assay in six-well plates with plasmids encoding wild-type hGLP1R, mGLP1R, hGIPR or mGIPR using Lipofectamine 2000. AD293 cells were authenticated at source using STR profiling. Cells were detached and treated with a range of agonist concentrations in serum-free DMEM + 0.1% BSA for 30 min at 37 °C in 96-well plates, followed by the addition of lysis buffer 2 (Cisbio) at a 1:2 ratio. Lysates were further diluted 1:10 to avoid spectral interference from the higher concentrations of fluorescent ligands in the HTRF assay, and the concentration of cAMP was determined after the addition of cAMP Dynamic detection reagents (Cisbio). Three-parameter logistic fitting was used to determine signalling potencies for each ligand, with EC<sub>50</sub> ratios relative to the cognate ligand for each receptor used to establish test agonist selectivity for GLP1R versus GIPR.</p></section><section id="Sec18"><h3 class="pmc_sec_title">NanoBRET binding assays</h3>
<p id="Par37">HEK293T cells (RRID:<a href="https://scicrunch.org/resolver/CVCL_0063/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CVCL_0063</a>) were cultured in DMEM/F12 GlutaMAX (ThermoFisher), supplemented with 10% FBS and 1% antibiotic-antimycotic solution and cultured at 37 °C, 5% CO<sub>2</sub>. HEK293T cells were authenticated at source using STR profiling. Cells transiently expressing Nluc–GLP1R or Nluc–GIPR were seeded onto white 96-well plates and cultured for 24 h. Media was then removed and the cells were incubated in PBS supplemented with 0.1% BSA and 0.01% NanoGlo (Promega). For saturation binding assays, daLUXendins were added across the concentration range 0.1–31.6 nM, in the absence or presence of 1 μM GIP and 1 μM Exendin-9 to determine specific binding. For competition binding assays, cells were co-treated with 10 nM daLUXendin and GLP1 or GIP across the range 1 μM to 1 pM. Plates were read using a PheraSTAR microplate reader, using the NanoBRET filter module. BRET ratios (λ<sub>acceptor</sub>/λ<sub>donor</sub>) were calculated, and saturation data fit using the ‘One Site – Specific Binding’ equation of GraphPad Prism 10. Competition binding was fit using the ‘One Site – Fit Ki’ equation.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Glucose tolerance testing</h3>
<p id="Par38">Male and female 8–12 week old <em>Glp1r</em><sup>WT/WT</sup>, <em>Glp1r</em><sup>WT/KO</sup> and <em>Glp1r</em><sup>KO/KO</sup> (ref. <sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>) littermates (on a C57BL/6J background) were fasted for 4–6 h, with free access to water. Wild-type and heterozygous mice were used as controls, as loss of a single <em>Glp1r</em> allele was found to exert minimal influence on phenotype<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>. Tirzepatide and daLUXendin were administered at 10 nmol kg<sup>−1</sup> before intraperitoneal injection of 2 g kg<sup>−1</sup> glucose 60 min later. Glucose was measured in blood from the tail vein at 0, 15, 30, 60, 90 and 120 min post glucose challenge. Mice were socially housed in specific-pathogen-free conditions under a 12 h light–dark cycle with ad libitum access to food and water, relative humidity 55 ± 10% and temperature 21 ± 2 °C.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Food intake study</h3>
<p id="Par39">Male and female 12–14 week old C57BL/N mice were singly housed in a 12 h dark–light cycle (14:00–02:00 h) and habituated to FED3 feeding devices for 7 days before commencing the study<sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>. All mice were kept on a 12 h light–dark cycle at 20–24 °C and 45–65% relative humidity (typically 21 °C and 55%). On test days, mice were fasted for 3 h before onset of the dark phase by removal of the FED3 devices. At dark onset, mice were injected subcutaneously with either vehicle, daLUXendin660 (10 nmol kg<sup>−1</sup>) or tirzepatide (10 nmol kg<sup>−1</sup>), the FED3 devices were returned and food intake was recorded over a 24 h period. The study was performed using a three-way crossover design. A 1-week washout period was observed between experimental days. FED3 devices were checked, serviced and food was topped up daily.</p></section><section id="Sec21"><h3 class="pmc_sec_title">AD293 cell fluorescent probe labelling</h3>
<p id="Par40">AD293 cells (RRID:<a href="https://scicrunch.org/resolver/CVCL_9804/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CVCL_9804</a>) were grown in DMEM High Glucose supplemented with 10% FBS, 100 units per ml penicillin and 100 μg ml<sup>−1</sup> streptomycin and 1% glutamine (complete DMEM).</p>
<p id="Par41">Cells were transfected with 0.3 μl Lipofectamine 2000 per well and 50 ng DNA (SNAP_hGIPR or SNAP_hGLP1R plasmid) per well in 110 μl OptiMEM per well and incubated overnight at 37 °C, 5% CO<sub>2</sub>. Cells co-transfected with plasmids for two receptors harbouring orthogonal enzyme self-labels (SNAP_GIPR and Halo_GLP1R plasmid) received 50 ng of each DNA. Control, non-transfected cells were cultured overnight in 50 μl OptiMEM without the addition of Lipofectamine 2000 or DNA. The next day, culture media was removed and 50 μl of labelling solution or complete DMEM (for unlabelled control) was added to each well.</p>
<p id="Par42">On the day after transfection with SNAP-GIPR and Halo-GLP1R, cells were incubated in triple probe solutions of either 500 nM daLUXendin544 with 500 nM SBG-Oregon Green (SBG-OG) and 500 nM CA-Sulfo646, or 500 nM daLUXendin660 with 500nM SBG-OG and 500 nM CA-Sulfo549, all in 50 μl complete DMEM for 55 min at 37 °C, 5% CO<sub>2</sub>. Additional wells of transfected cells were incubated in single probe solutions (500 nM daLUXendin544, 500 nM daLUXendin660, 500 nM SBG-OG, 500 nM CA-Sulfo549 or 500 nM CA-Sulfo646) or unlabelled complete DMEM in addition to non-transfected cells incubated in triple probe solutions, all as control wells. SNAP-tag and Halo-tag have been previously reported and are characterized elsewhere<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>.</p></section><section id="Sec22"><h3 class="pmc_sec_title">MIN6-CB4 cell fluorescent probe labelling</h3>
<p id="Par43">MIN6-CB4 cells were generated and phenotyped, as previously described<sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. Cells were grown to 70% confluency in MIN6 media (DMEM High Glucose supplemented with 15% FBS, 71 μM 2-mercaptoethanol, 2 mM glutamine, 100 units ml<sup>−1</sup> penicillin, 100 μg ml<sup>−1</sup> streptomycin). Cells were then seeded in 100 μl MIN6 media per well, on a glass-bottomed 96-well imaging plate previously coated with poly-<span class="font-variant-small-caps">l</span>-lysine 0.01%. The day after seeding, cells were incubated with either 500 nM daLUXendin660, 100 nM sGIP549 (GIPR probe)<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup> or 100 nM LUXendin551 (GLP1R probe)<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>, a combination of two or just complete MIN6 media for 1 h at 37 °C, 5% CO<sub>2</sub>.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Islet isolation</h3>
<p id="Par44">Male and female 8–12 week old CD1 and C57BL6/J mice, as well as GLP1R<sup>KO/KO</sup> (ref. <sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>) and GLP1R<sup>SNAP/SNAP</sup> (ref. <sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>) mice (both on a C57BL/6J background) were used as tissue donors. Mice were humanely killed using a schedule-1 method, and the common bile duct was injected with Serva NB8 (1 mg ml<sup>−1</sup>) collagenase. The inflated pancreas was dissected, and islets were isolated using Histopaque-1119 and 1083 (Sigma-Aldrich) gradients and cultured at 37 °C, 5% CO<sub>2</sub> in RPMI supplemented with 10% FBS (Gibco), 100 units per ml penicillin and 100 μg ml<sup>−1</sup> streptomycin. Islets were used up to 4 days after isolation.</p></section><section id="Sec24"><h3 class="pmc_sec_title">Islet labelling and immunostaining</h3>
<p id="Par45">Size-matched wild-type or GLP1R<sup>KO/KO</sup> islets were incubated in 100 nM, 500 nM or 1 μM daLUXendins, sGIP549, sGIP648, LUXendin551 or LUXendin645 for 1 h at 37 °C, 5% CO<sub>2</sub>, before washing twice.</p>
<p id="Par46">GLP1R<sup>SNAP/SNAP</sup> islets were incubated with 500 nM BG-Sulfo549 or BG-Sulfo646 and/or another orthogonal fluorescent ligand for 1 h at 37 °C, 5% CO<sub>2</sub>, before washing three times.</p>
<p id="Par47">For immunostaining, labelled islets were washed three times with PBS, then incubated with 2–4% formalin for 15 min at room temperature (16–25 °C). Islets were again washed three times with PBS, then incubated in permeabilizing blocking buffer for 1 h at room temperature before incubation with primary antibody overnight at 4 °C. The following day, islets were incubated with secondary antibody for 2 h at room temperature before mounting onto microscope slides with VECTASHIELD HardSet with DAPI or Everbrite Hardset. Primary and secondary antibodies are listed in Supplementary Table <a href="#MOESM1" class="usa-link">5</a>.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Brain and pancreas labelling</h3>
<p id="Par48">To assess brain and pancreas access following peripheral administration, GLP1R-Cre:tdRFP (GLP1R-tdRFP) and GIPR-Cre:GFP (GIPR-GFP) mice<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup> (both on a C57BL/N background) were injected intravenously into the tail vein with 100 nmol kg<sup>−1</sup> daLUXendin. Then, 40 min later, mice were terminally anaesthetized with pentobarbital (200 mg kg<sup>−1</sup>) and perfused with ice-cold 0.1 M PBS followed by 4% formalin solution.</p>
<p id="Par49">For brain tissue analysis, GLP1R-tdRFP mice and GIPR-Cre:GCaMP6 (GIPR-GCaMP6) mice<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup> were terminally anaesthetized using ketamine hydrochloride (Ketavet, Zoetis; 75 mg kg<sup>−1</sup>, intraperitoneally) and medetomidine hydrochloride (Domitor, OrionPharma; 1 mg kg<sup>−1</sup>, intraperitoneally). Meloxicam (Metacam, Boehringer Ingelheim; 5 mg kg<sup>−1</sup>, subcutaneously) was given for peri-surgery analgesia. Mice were placed in a stereotaxic frame, and daLUXendin was injected unilaterally into the lateral ventricle at doses of 5 nmol kg<sup>−1</sup> body weight at a rate of 1 µl min<sup>−1</sup>. Coordinates relative to bregma were A/P −0.5 mm; D/V −2.5 mm; M/L 1 mm. At 1 h post injection, mice were perfused with ice-cold 0.1 M PBS followed by 4% formalin solution.</p>
<p id="Par50">All brains were cryo-sectioned coronally at 30 µm and mounted onto microscope slides with VECTASHIELD antifade mounting medium (H-1000).</p></section><section id="Sec26"><h3 class="pmc_sec_title">Immunofluorescence labelling in brain tissue</h3>
<p id="Par51">Brains were cryo-sectioned coronally at 30 µm and sections processed for amplification of fluorescent reporter signals by immunofluorescence labelling of vimentin (a marker for ependymal cells and tanycytes). Antigen retrieval of free-floating sections was performed using sodium citrate buffer at 80 °C for 20 min. Sections were next blocked in 5% normal donkey serum, 0.2% Triton X-100 for 1 h and then incubated overnight in primary antibody (in blocking solution) at room temperature (primary antibody: chicken anti-vimentin, Ab24525, Abcam; 1:750). Sections were next incubated for 2 h in secondary antibody (in 1% normal donkey serum, 0.2% Triton X-100) at room temperature (secondary antibody: donkey anti-chicken IgY (H+L) highly cross-adsorbed secondary antibody, Alexa Fluor 488, A78948, Thermo Fisher Scientific; 1:500). Sections were stained with DAPI to mark nuclei, then mounted on Superfrost Plus slides and cover-slipped using Prolong Antifade medium.</p>
<p id="Par52">Sections were imaged on an inverted Leica SP8 confocal microscope using either a ×25 or ×63 oil immersion objective. Three-dimensional reconstructions of daLUXendin660-labelled tissue or antibody-stained cells were rendered using the Surfaces function in Imaris (v.10.1.1) (Oxford Instruments). Opaque surfaces are three-dimensional reconstructions of overlapping areas of daLUXendin660 labelling and antibody staining created using the Coloc function in Imaris. Primary and secondary antibodies are listed in Supplementary Table <a href="#MOESM1" class="usa-link">5</a>.</p></section><section id="Sec27"><h3 class="pmc_sec_title">RNAscope in situ hybridization</h3>
<p id="Par53">Midbrain sections (30 µm) containing the ARH from a GIPR-Cre:GCaMP6 (GIPR-GCaMP6) mouse intracerebroventricularly administered daLUXendin660 (3.3 nmol kg<sup>−1</sup> body weight) were collected on Superfrost Plus slides and allowed to air-dry at room temperature for 1 h. Slides were then dipped in molecular-grade ethanol and further air-dried overnight at room temperature. RNAscope in situ hybridization was performed on these sections using the RNAscope Multiplex Fluorescent Kit (v.2) (Advanced Cell Diagnostics) as per the manufacturer’s instructions, with a modification to the pre-treatment procedure (Protease IV incubation conducted for 20 min at room temperature). Sections were processed for in situ hybridization of <em>Glp1r</em> mRNA (cat. no. 418851-C2, Advanced Cell Diagnostics). Following hybridization, slides were cover-slipped using Prolong Antifade medium.</p></section><section id="Sec28"><h3 class="pmc_sec_title">iPS cell-derived islet-like structures</h3>
<p id="Par54">Human iPS cells (ALSTEM, iPS11) were maintained on iPS cell-qualified Matrigel (Corning, 354277) in mTeSR+ media (StemCell Technologies, 05826). ALSTEM iPS11 cells were authenticated at source by testing for expression of OCT4 and TRA-1-60, as well as alkaline phosphatase activity. Differentiation to islet-like structures (SC-islets) was carried out in a suspension-based, magnetic CELLSPIN bioreactor system (PFEIFFER). Differentiation media was changed daily by letting spheres settle by gravity for 3–10 min. Most of the supernatant was removed by aspiration; fresh media was added and bioreactors were placed back on the stirrer system. SC-islet differentiation was based on published protocols<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>,<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a></sup></p></section><section id="Sec29"><h3 class="pmc_sec_title">Microscopy</h3>
<p id="Par55">Live or fixed cell and tissue imaging was performed with either (1) Zeiss LSM780/LSM880 meta-confocal microscopes equipped with GaAsP spectral detectors and ×40 and ×63/1.2 NA water objectives; (2) an Olympus FV3000 confocal microscope equipped with GaAsP spectral detectors and UPLSAPO ×60/1.30 NA silicone and ×60/1.41 NA oil objectives; or (3) an Olympus FV4000 confocal microscope equipped with SilVIR spectral detectors and a UPLSAPO ×60/1.41 NA oil objective. Excitation (ex) and emission (em) wavelengths (in nm) are as follows: sGIP549 (λex 561, λem 568–621), sGIP648 (λex 633, λem 639–692), LUXendin551 (λex 561, λem 568–621), LUXendin645 (λex 633, λem 639–692), daLUXendin544(+) (λex 561, λem 569–623), daLUXendin660(+) (λex 633, λem 640–694), SBG-OG (λex 488, λem 496–542), BG-Sulfo549 (λex 561, λem 569–623), BG-Sulfo646 (λex 633, λem 641–694), CA-Sulfo549 (λex 561, λem 568–613), CA-Sulfo646 (λex 633, λem 640–694), Hoechst (λex 405, λem 410–488), Alexa488 (λex 488, λem 496–542), DyLight488 (λex 488, λem 496–542) and DyLight633 (λex 633, λem 640–694). Zen 2012 or Olympus cellSens (v.3.2) were used for image acquisition and analysis.</p></section><section id="Sec30"><h3 class="pmc_sec_title">dSTORM nanoscopy</h3>
<p id="Par56">Islets were labelled with LUXendin645 (500 nM), sGIP648 (1 µM) or daLUXendin (1 µM), before fixation in 2–4% formalin for 15–30 min. Islets were mounted on cavity slides, submerged in STORM buffer (Abbelight) and sealed using a 170 µm coverslip and dental resin. Samples were imaged in HILO mode on an Evident/Abbelight SAFe 180 system, using a ×100/1.5 NA Olympus UPLAPO100XOHR objective. LUXendin645, sGIP648 or daLUXendin660 (all Cy5) were pumped to the dark state using an Oxxius laser combiner and 600 mW 640 nm Coherent Obis diode laser before initiation of photoblinking. Single-molecule events were recorded using an LP650 filter with an integration time of 50 ms on a Hamamatsu ORCA-Fusion sCMOS for 20,000–40,000 frames. Localizations were extracted and images reconstructed using Abbelight NEO software. Density-based spatial clustering of applications with noise (DBSCAN) was used to determine localization clustering, implemented in Abbelight NEO software (v.39), with ε = 25 nm (the average precision of the data) and minPts = 8. Results were confirmed using a custom RNA segmentation and DBSCAN routine implemented in R Project (v.4.4.3) (<a href="https://cran.r-project.org/web/packages/dbscan/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cran.r-project.org/web/packages/dbscan/index.html</a>)<sup><a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup>.</p></section><section id="Sec31"><h3 class="pmc_sec_title">Live confocal and STED imaging</h3>
<p id="Par57">Live confocal and STED imaging of CHO-K1:SNAP-GLP1R:Halo-GIPR cells (CHO-K1, RRID:<a href="https://scicrunch.org/resolver/CVCL_0214/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CVCL_0214</a>) was performed on a STEDYCON system (Abberior Instruments), mounted on a Nikon Eclipse TI research microscope equipped with a Plan APO Lambda ×100/1.45 NA oil objective (Nikon) and controlled by NIS Elements (Nikon). CHO-K1 cells were authenticated at source using DNA barcoding and DNA profiling. An incubation chamber surrounding the microscope setup was set to 37 °C 24 h before live-cell imaging. To provide stable focus during imaging, the Perfect Focus System (Nikon) was used. Imaging was performed in FluoroBrite Medium (Gibco) at 37 °C. Excitation was delivered with a 405, 488, 568 or 640 nm diode laser, and emission was detected with avalanche photodiodes at 461, 520, 566 or 671 nm, respectively. Live STED images were acquired with a 640 nm excitation laser, 775 nm depletion laser (at 20% intensity) and 671 nm detector (gate, 1–7 ns). Pixel size was set to 30 nm × 30 nm, with 10 µs pixel dwell time, and a line accumulation of 1 was used during acquisition. STEDYCON 9.0.799-g22f03ed2 software was used for image acquisition and analysis.</p></section><section id="Sec32"><h3 class="pmc_sec_title">Single particle tracking</h3>
<p id="Par58">MIN6-CB4 cells were labelled with 500 pM daLUXendin660 in complete media for 20 min at 37 °C and washed three times in HEPES-bicarbonate buffer, ensuring sparse labelling of GLP1R/GIPR. Cells were mounted on cavity slides and imaged in HEPES-bicarbonate buffer supplemented with 11 mM <span class="font-variant-small-caps">d</span>-glucose before TIRF imaging at 40 Hz using an Evident/Abbelight SAFe 180 system and a ×100/1.5 NA Olympus UPLAPO100XOHR objective. Single particles were recorded using an LP650 filter with an integration time of 25 ms on a Hamamatsu ORCA-Fusion sCMOS for 1,750 frames. Single particle analysis was performed using the Trackmate plugin for ImageJ<sup><a href="#CR51" class="usa-link" aria-describedby="CR51">51</a></sup>, with trajectories shown as maximum displacement.</p></section><section id="Sec33"><h3 class="pmc_sec_title">Image analysis</h3>
<p id="Par59">Probe labelling was analysed using corrected total cell fluorescence, which is integrated density − (area of selected cell × mean fluorescence of background readings)<sup><a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>,<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a></sup>. Colocalization was determined using Manders’ coefficient, which calculates the proportion of pixels in one channel that also show intensity from both channels. Full width at half maximum was used to analyse labelling patterns at the membrane versus cytoplasm. All analyses were performed in ImageJ (NIH), with brightness and contrast linearly adjusted across the entire image for presentation purposes and applied equally between all states under examination.</p></section><section id="Sec34"><h3 class="pmc_sec_title">Statistics and reproducibility</h3>
<p id="Par60">Data distribution was assessed using the D’Agostino–Pearson normality test. Pairwise comparisons were made using unpaired <em>t</em>-tests. For non-parametric data, pairwise comparisons were made using a Mann–Whitney test. Multiple comparisons were made using either one-way ANOVA (parametric), two-way ANOVA (parametric) or Kruskal–Wallis test (non-parametric), with pairwise comparisons made using either Šídák’s or Dunn’s tests, or the two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli. GraphPad Prism 9 and 10 were used for all statistical analyses. Values are presented as means; error bars, s.e.m.; <em>P</em> values less than 0.05 were considered significant.</p>
<p id="Par61">For animal studies, each independent replicate corresponds to a separate animal. For cell line studies, the independent replicate corresponds to experiments performed on different days or using cells split from separate flasks. Variation between individual islets or cells was greater than variation of the mean between animals; therefore, they are considered separate data points for analysis purposes. For representative images, the experiment was repeated the same number of times as the related quantification, always with similar results. If the <em>n</em> number occupies a range of samples or animals, the lowest value is provided as per journal guidelines. Hence, the number of data points on the graph may be higher than the stated sample size.</p></section><section id="Sec35"><h3 class="pmc_sec_title">Reporting summary</h3>
<p id="Par62">Further information on research design is available in the <a href="#MOESM2" class="usa-link">Nature Portfolio Reporting Summary</a> linked to this article.</p></section></section><section id="Sec37"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link"><span>Supplementary Information</span></a><sup> (978.5KB, pdf) </sup><p>Supplementary Figs. 1 and 2, Supplementary Tables 1–5, Supplementary Note 1</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting Summary</a><sup> (2.8MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM3_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Supplementary Data 1</span></a><sup> (19.6KB, xlsx) </sup><p>Statistical Source Data for Supplementary Fig. 2</p>
</div></div></section></section><section id="Sec38"><h2 class="pmc_sec_title">Source data</h2>
<section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Fig. 1</span></a><sup> (48.7KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM5"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM5_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Fig. 2</span></a><sup> (27.9KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM6"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM6_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Fig. 4</span></a><sup> (25.5KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM7"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM7_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Extended Data Fig./Table 1</span></a><sup> (12.7KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM8"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM8_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Extended Data Fig./Table 2</span></a><sup> (579.6KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM9"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM9_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Extended Data Fig./Table 3</span></a><sup> (31.2KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>A.dB. was supported by a Medical Research Council (MRC) Clinical Research Training Fellowship (MR/W000881/2). D.J.H. was supported by grants from MRC (MR/S025618/1) and Diabetes UK (17/0005681 and 22/0006389). This research was funded, in whole or in part, by UK Research and Innovation (EP/X026833/1) (to D.J.H.). This project has received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation programme (Starting Grant 715884 to D.J.H.) and from the European Union’s Horizon Europe Framework Programme (deuterON, grant agreement no. 101042046 to J.B.). This work was supported on behalf of the ‘Steve Morgan Foundation Type 1 Diabetes Grand Challenge’ by Diabetes UK and the Steve Morgan Foundation (grant number 23/0006627 to D.J.H. and J.B.). A.H.S. was supported by a Novo Nordisk–Oxford Fellowship. D.N. was supported by a Diabetes UK R.D. Lawrence Fellowship (23/0006509). Research in the Reimann/Gribble laboratories is currently funded by jointly held grants from the Wellcome Trust (220271/Z/20/Z) and the MRC (MRC_MC_UU_12012/3). G.L. is a Royal Society Industry Fellow (INF/R2/212001) and, together with A.P., was supported by the Biotechnology and Biological Sciences Research Council (BB/W014831/1). S.T. was supported by MRC (MR/X003604/1) and the ‘EFSD European Research Programme on New Targets for Type 2 Diabetes supported by an educational research grant from MSD’. A.E.A. is supported by the Novo Nordisk Fonden/European Federation for the Study of Diabetes Future Leaders Award. B.J. is supported by an MRC Clinician Scientist Fellowship (MR/Y00132X/1), as well as project grants from the MRC and Diabetes UK. The Section of Endocrinology at Imperial College London is funded by grants from the MRC, National Institute for Health Research (NIHR) and is supported by the NIHR Biomedical Research Centre Funding Scheme and the NIHR/Imperial Clinical Research Facility. The Oxford Centre for Diabetes, Endocrinology and Metabolism at the University of Oxford is supported by the NIHR Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health. The project involves an element of animal work not funded by the NIHR but by another funder, as well as an element focussed on patients and people appropriately funded by the NIHR. We thank R. Birke and I. Kretzschmer (both FMP) for technical support. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.</p></section><section id="App1" class="app"><section id="Sec36"><h3 class="pmc_sec_title">Extended data</h3></section></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>A.dB., A.R., S.A., J.T., A.H.S., W.J., N.S.F-B, J.P.P.T., K.V., D.N., A.P., J.A., T.S. and B.J. performed experiments and analysed the data. C.H., B.G-F. and K.R. performed chemical synthesis and characterization. S.M. validated and provided a cell line. F.R. provided genetically modified reporter mice. A.H.S., G.C., A.E. and C.A. generated SC-islets. D.M.O. and D.J.N. provided code and analysed images. A.E.A. and S.T. conceptualized and supervised brain labelling and food intake experiments. J.T. and G.L. designed and supervised pharmacology experiments. J.B. and D.J.H. conceived the studies, designed and supervised experiments and wrote the manuscript with input from all authors.</p></section><section id="notes2"><h2 class="pmc_sec_title">Peer review</h2>
<section id="FPar3"><h3 class="pmc_sec_title">Peer review information</h3>
<p id="Par65"><em>Nature Metabolism</em> thanks Timo Müller and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: Christoph Schmitt, in collaboration with the <em>Nature Metabolism</em> team.</p></section></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Datasets generated and/or analysed during the current study are available from the corresponding authors upon request. Owing to their large size, individual raw image files are available upon request. daLUXendins are subject to a Material Transfer Agreement and the ability to manufacture and supply. All requests for reagents and data will be handled by J.B. or D.J.H., who will respond within 30 working days. <a href="#Sec38" class="usa-link">Source data</a> are provided with this paper.</p></section><section id="FPar4"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par66">J.A., M.C., A.E. and C.A. are employees of Novo Nordisk A/S. A.E.A. is an employee of AstraZeneca plc. University of Birmingham and Leibniz-Forschungsinstitut für Molekulare Pharmakologie have filed a patent (WO2024133236, ‘Peptide conjugates for labelling endogenous GIPR and GLP1R’, inventors David J. Hodson and Johannes Broichhagen), which covers daLUXendins described in the present study. Oxford University Innovation filed a PCT patent application on 14 March 2025 (PCT/GB2025/050523, entitled ‘Combination therapy’ and with the inventors being David J. Hodson, Katrina Viloria, Ali Shilleh and Martin Hewison) that encompasses elements of the work described in the present study. This PCT patent application is due to be published on 14 September 2025. D.J.H. and J.B. receive licensing revenue from Celtarys Research for the provision of GLP1R/GIPR chemical probes used in the present study, including LUXendins, sGIPs and daLUXendins. The remaining authors declare no competing interests.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Johannes Broichhagen, Email: Broichhagen@fmp-berlin.de.</p>
<p>David J. Hodson, Email: david.hodson@ocdem.ox.ac.uk</p></section><section id="sec39"><section id="FPar1"><h3 class="pmc_sec_title">Extended data</h3>
<p id="Par63">is available for this paper at 10.1038/s42255-025-01342-6.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Supplementary information</h3>
<p id="Par64">The online version contains supplementary material available at 10.1038/s42255-025-01342-6.</p></section></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Liskiewicz, A. et al. Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice. <em>Nat. Metab.</em><strong>5</strong>, 2075–2085 (2023).
</cite> [<a href="https://doi.org/10.1038/s42255-023-00931-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10730394/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37946085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liskiewicz,%20A.%20et%20al.%20Glucose-dependent%20insulinotropic%20polypeptide%20regulates%20body%20weight%20and%20food%20intake%20via%20GABAergic%20neurons%20in%20mice.%20Nat.%20Metab.5,%202075%E2%80%932085%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Scrocchi, L. A. et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. <em>Nat. Med.</em><strong>2</strong>, 1254–1258 (1996).
</cite> [<a href="https://doi.org/10.1038/nm1196-1254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8898756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scrocchi,%20L.%20A.%20et%20al.%20Glucose%20intolerance%20but%20normal%20satiety%20in%20mice%20with%20a%20null%20mutation%20in%20the%20glucagon-like%20peptide%201%20receptor%20gene.%20Nat.%20Med.2,%201254%E2%80%931258%20(1996)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Turton, M. D. et al. A role for glucagon-like peptide-1 in the central regulation of feeding. <em>Nature</em><strong>379</strong>, 69–72 (1996).
</cite> [<a href="https://doi.org/10.1038/379069a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8538742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Turton,%20M.%20D.%20et%20al.%20A%20role%20for%20glucagon-like%20peptide-1%20in%20the%20central%20regulation%20of%20feeding.%20Nature379,%2069%E2%80%9372%20(1996)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Pi-Sunyer, X. et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. <em>N. Engl. J. Med.</em><strong>373</strong>, 11–22 (2015).
</cite> [<a href="https://doi.org/10.1056/NEJMoa1411892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26132939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pi-Sunyer,%20X.%20et%20al.%20A%20randomized,%20controlled%20trial%20of%203.0%20mg%20of%20liraglutide%20in%20weight%20management.%20N.%20Engl.%20J.%20Med.373,%2011%E2%80%9322%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Wilding, J. P. H. et al. Once-weekly semaglutide in adults with overweight or obesity. <em>N. Engl. J. Med.</em><strong>384</strong>, 989 (2021).
</cite> [<a href="https://doi.org/10.1056/NEJMoa2032183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33567185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wilding,%20J.%20P.%20H.%20et%20al.%20Once-weekly%20semaglutide%20in%20adults%20with%20overweight%20or%20obesity.%20N.%20Engl.%20J.%20Med.384,%20989%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Miyawaki, K. et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. <em>Nat. Med.</em><strong>8</strong>, 738–742 (2002).
</cite> [<a href="https://doi.org/10.1038/nm727" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12068290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miyawaki,%20K.%20et%20al.%20Inhibition%20of%20gastric%20inhibitory%20polypeptide%20signaling%20prevents%20obesity.%20Nat.%20Med.8,%20738%E2%80%93742%20(2002)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Nauck, M. A. et al. Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. <em>J. Clin. Invest.</em><strong>91</strong>, 301–307 (1993).
</cite> [<a href="https://doi.org/10.1172/JCI116186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC330027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8423228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nauck,%20M.%20A.%20et%20al.%20Preserved%20incretin%20activity%20of%20glucagon-like%20peptide%201%20%5B7%E2%80%9336%20amide%5D%20but%20not%20of%20synthetic%20human%20gastric%20inhibitory%20polypeptide%20in%20patients%20with%20type-2%20diabetes%20mellitus.%20J.%20Clin.%20Invest.91,%20301%E2%80%93307%20(1993)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Campbell, J. E. et al. TCF1 links GIPR signaling to the control of beta cell function and survival. <em>Nat. Med.</em><strong>22</strong>, 84–90 (2016).
</cite> [<a href="https://doi.org/10.1038/nm.3997" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26642437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Campbell,%20J.%20E.%20et%20al.%20TCF1%20links%20GIPR%20signaling%20to%20the%20control%20of%20beta%20cell%20function%20and%20survival.%20Nat.%20Med.22,%2084%E2%80%9390%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Campbell, J. E. et al. GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications. <em>Cell Metab.</em><strong>35</strong>, 1519–1529 (2023).
</cite> [<a href="https://doi.org/10.1016/j.cmet.2023.07.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10528201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37591245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Campbell,%20J.%20E.%20et%20al.%20GIPR/GLP-1R%20dual%20agonist%20therapies%20for%20diabetes%20and%20weight%20loss%E2%80%94chemistry,%20physiology,%20and%20clinical%20applications.%20Cell%20Metab.35,%201519%E2%80%931529%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Willard, F. S. et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. <em>JCI Insight</em><strong>5</strong>, e140532 (2020).
</cite> [<a href="https://doi.org/10.1172/jci.insight.140532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7526454/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32730231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Willard,%20F.%20S.%20et%20al.%20Tirzepatide%20is%20an%20imbalanced%20and%20biased%20dual%20GIP%20and%20GLP-1%20receptor%20agonist.%20JCI%20Insight5,%20e140532%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>El, K. et al. The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets. <em>Nat. Metab.</em><strong>5</strong>, 945–954 (2023).
</cite> [<a href="https://doi.org/10.1038/s42255-023-00811-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10290954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37277609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?El,%20K.%20et%20al.%20The%20incretin%20co-agonist%20tirzepatide%20requires%20GIPR%20for%20hormone%20secretion%20from%20human%20islets.%20Nat.%20Metab.5,%20945%E2%80%93954%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Sun, B. et al. Structural determinants of dual incretin receptor agonism by tirzepatide. <em>Proc. Natl Acad. Sci. USA</em><strong>119</strong>, e2116506119 (2022).
</cite> [<a href="https://doi.org/10.1073/pnas.2116506119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9060465/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35333651/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun,%20B.%20et%20al.%20Structural%20determinants%20of%20dual%20incretin%20receptor%20agonism%20by%20tirzepatide.%20Proc.%20Natl%20Acad.%20Sci.%20USA119,%20e2116506119%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Ast, J., Broichhagen, J. &amp; Hodson, D. J. Reagents and models for detecting endogenous GLP1R and GIPR. <em>EBioMedicine</em><strong>74</strong>, 103739 (2021).
</cite> [<a href="https://doi.org/10.1016/j.ebiom.2021.103739" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8669301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34911028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ast,%20J.,%20Broichhagen,%20J.%20&amp;%20Hodson,%20D.%20J.%20Reagents%20and%20models%20for%20detecting%20endogenous%20GLP1R%20and%20GIPR.%20EBioMedicine74,%20103739%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Adriaenssens, A. E. et al. Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake. <em>Cell Metab.</em><strong>30</strong>, 987–996.e6 (2019).
</cite> [<a href="https://doi.org/10.1016/j.cmet.2019.07.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6838660/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31447324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Adriaenssens,%20A.%20E.%20et%20al.%20Glucose-dependent%20insulinotropic%20polypeptide%20receptor-expressing%20cells%20in%20the%20hypothalamus%20regulate%20food%20intake.%20Cell%20Metab.30,%20987%E2%80%93996.e6%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Richards, P. et al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. <em>Diabetes</em><strong>63</strong>, 1224–1233 (2013).
</cite> [<a href="https://doi.org/10.2337/db13-1440" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4092212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24296712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Richards,%20P.%20et%20al.%20Identification%20and%20characterization%20of%20GLP-1%20receptor-expressing%20cells%20using%20a%20new%20transgenic%20mouse%20model.%20Diabetes63,%201224%E2%80%931233%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Ast, J. et al. Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling. <em>Nat. Commun.</em><strong>14</strong>, 301 (2023).
</cite> [<a href="https://doi.org/10.1038/s41467-022-35716-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9849236/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36653347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ast,%20J.%20et%20al.%20Revealing%20the%20tissue-level%20complexity%20of%20endogenous%20glucagon-like%20peptide-1%20receptor%20expression%20and%20signaling.%20Nat.%20Commun.14,%20301%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Adriaenssens, A. et al. Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding. <em>JCI Insight</em><strong>8</strong>, e164921 (2023).
</cite> [<a href="https://doi.org/10.1172/jci.insight.164921" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10322681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37212283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Adriaenssens,%20A.%20et%20al.%20Hypothalamic%20and%20brainstem%20glucose-dependent%20insulinotropic%20polypeptide%20receptor%20neurons%20employ%20distinct%20mechanisms%20to%20affect%20feeding.%20JCI%20Insight8,%20e164921%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Ast, J. et al. Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics. <em>Nat. Commun.</em><strong>11</strong>, 467 (2020).
</cite> [<a href="https://doi.org/10.1038/s41467-020-14309-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6981144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31980626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ast,%20J.%20et%20al.%20Super-resolution%20microscopy%20compatible%20fluorescent%20probes%20reveal%20endogenous%20glucagon-like%20peptide-1%20receptor%20distribution%20and%20dynamics.%20Nat.%20Commun.11,%20467%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Ast, J. et al. Expanded LUXendin color palette for GLP1R detection and visualization in vitro and in vivo. <em>JACS Au</em><strong>2</strong>, 1007–1017 (2022).
</cite> [<a href="https://doi.org/10.1021/jacsau.2c00130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9088800/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35557759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ast,%20J.%20et%20al.%20Expanded%20LUXendin%20color%20palette%20for%20GLP1R%20detection%20and%20visualization%20in%20vitro%20and%20in%20vivo.%20JACS%20Au2,%201007%E2%80%931017%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Gray, S. M. et al. Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells. <em>J. Biol. Chem.</em><strong>295</strong>, 11529–11541 (2020).
</cite> [<a href="https://doi.org/10.1074/jbc.RA120.014368" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7450118/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32554468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gray,%20S.%20M.%20et%20al.%20Discordance%20between%20GLP-1R%20gene%20and%20protein%20expression%20in%20mouse%20pancreatic%20islet%20cells.%20J.%20Biol.%20Chem.295,%2011529%E2%80%9311541%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Shilleh, A. H., Viloria, K., Broichhagen, J., Campbell, J. E. &amp; Hodson, D. J. GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells. <em>Peptides</em><strong>175</strong>, 171179 (2024).
</cite> [<a href="https://doi.org/10.1016/j.peptides.2024.171179" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38360354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shilleh,%20A.%20H.,%20Viloria,%20K.,%20Broichhagen,%20J.,%20Campbell,%20J.%20E.%20&amp;%20Hodson,%20D.%20J.%20GLP1R%20and%20GIPR%20expression%20and%20signaling%20in%20pancreatic%20alpha%20cells,%20beta%20cells%20and%20delta%20cells.%20Peptides175,%20171179%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Romanò, N. et al. Median eminence blood flow influences food intake by regulating ghrelin access to the metabolic brain. <em>JCI Insight</em><strong>8</strong>, e165763 (2023).
</cite> [<a href="https://doi.org/10.1172/jci.insight.165763" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9977422/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36574295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roman%C3%B2,%20N.%20et%20al.%20Median%20eminence%20blood%20flow%20influences%20food%20intake%20by%20regulating%20ghrelin%20access%20to%20the%20metabolic%20brain.%20JCI%20Insight8,%20e165763%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Michau, A. et al. Metabolism regulates exposure of pancreatic islets to circulating molecules in vivo. <em>Diabetes</em><strong>65</strong>, 463–475 (2016).
</cite> [<a href="https://doi.org/10.2337/db15-1168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26581596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Michau,%20A.%20et%20al.%20Metabolism%20regulates%20exposure%20of%20pancreatic%20islets%20to%20circulating%20molecules%20in%20vivo.%20Diabetes65,%20463%E2%80%93475%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Zhang, Y. et al. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. <em>Nature</em><strong>546</strong>, 248–253 (2017).
</cite> [<a href="https://doi.org/10.1038/nature22394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5587415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28538729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang,%20Y.%20et%20al.%20Cryo-EM%20structure%20of%20the%20activated%20GLP-1%20receptor%20in%20complex%20with%20a%20G%20protein.%20Nature546,%20248%E2%80%93253%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Liang, Y.-L. et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor–Gs complex. <em>Nature</em><strong>555</strong>, 121–125 (2018).
</cite> [<a href="https://doi.org/10.1038/nature25773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29466332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang,%20Y.-L.%20et%20al.%20Phase-plate%20cryo-EM%20structure%20of%20a%20biased%20agonist-bound%20human%20GLP-1%20receptor%E2%80%93Gs%20complex.%20Nature555,%20121%E2%80%93125%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Zhao, F. et al. Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. <em>Nat. Commun.</em><strong>13</strong>, 1057 (2022).
</cite> [<a href="https://doi.org/10.1038/s41467-022-28683-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8881610/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35217653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao,%20F.%20et%20al.%20Structural%20insights%20into%20multiplexed%20pharmacological%20actions%20of%20tirzepatide%20and%20peptide%2020%20at%20the%20GIP,%20GLP-1%20or%20glucagon%20receptors.%20Nat.%20Commun.13,%201057%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Thorens, B. et al. Cloning and functional expression of the human islet GLP-1 receptor: demonstration that exendin-4 is an agonist and exendin-(9–39) an antagonist of the receptor. <em>Diabetes</em><strong>42</strong>, 1678–1682 (1993).
</cite> [<a href="https://doi.org/10.2337/diab.42.11.1678" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8405712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thorens,%20B.%20et%20al.%20Cloning%20and%20functional%20expression%20of%20the%20human%20islet%20GLP-1%20receptor:%20demonstration%20that%20exendin-4%20is%20an%20agonist%20and%20exendin-(9%E2%80%9339)%20an%20antagonist%20of%20the%20receptor.%20Diabetes42,%201678%E2%80%931682%20(1993)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Mroz, P. A. et al. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism. <em>Mol. Metab.</em><strong>20</strong>, 51–62 (2019).
</cite> [<a href="https://doi.org/10.1016/j.molmet.2018.12.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6358549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30578168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mroz,%20P.%20A.%20et%20al.%20Optimized%20GIP%20analogs%20promote%20body%20weight%20lowering%20in%20mice%20through%20GIPR%20agonism%20not%20antagonism.%20Mol.%20Metab.20,%2051%E2%80%9362%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Coskun, T. et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept. <em>Mol. Metab.</em><strong>18</strong>, 3–14 (2018).
</cite> [<a href="https://doi.org/10.1016/j.molmet.2018.09.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6308032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30473097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Coskun,%20T.%20et%20al.%20LY3298176,%20a%20novel%20dual%20GIP%20and%20GLP-1%20receptor%20agonist%20for%20the%20treatment%20of%20type%202%20diabetes%20mellitus:%20from%20discovery%20to%20clinical%20proof%20of%20concept.%20Mol.%20Metab.18,%203%E2%80%9314%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Poc, P. et al. Interrogating surface versus intracellular transmembrane receptor populations using cell-impermeable SNAP-tag substrates. <em>Chem. Sci.</em><strong>11</strong>, 7871–7883 (2020).
</cite> [<a href="https://doi.org/10.1039/d0sc02794d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8163392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34123074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Poc,%20P.%20et%20al.%20Interrogating%20surface%20versus%20intracellular%20transmembrane%20receptor%20populations%20using%20cell-impermeable%20SNAP-tag%20substrates.%20Chem.%20Sci.11,%207871%E2%80%937883%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Birke, R. et al. Sulfonated red and far-red rhodamines to visualize SNAP- and Halo-tagged cell surface proteins. <em>Org. Biomol. Chem.</em><strong>20</strong>, 5967–5980 (2022).
</cite> [<a href="https://doi.org/10.1039/d1ob02216d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9346974/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35188523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Birke,%20R.%20et%20al.%20Sulfonated%20red%20and%20far-red%20rhodamines%20to%20visualize%20SNAP-%20and%20Halo-tagged%20cell%20surface%20proteins.%20Org.%20Biomol.%20Chem.20,%205967%E2%80%935980%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Cnop, M. et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. <em>Diabetologia</em><strong>53</strong>, 321–330 (2009).
</cite> [<a href="https://doi.org/10.1007/s00125-009-1562-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19855953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cnop,%20M.%20et%20al.%20The%20long%20lifespan%20and%20low%20turnover%20of%20human%20islet%20beta%20cells%20estimated%20by%20mathematical%20modelling%20of%20lipofuscin%20accumulation.%20Diabetologia53,%20321%E2%80%93330%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Shapiro, A. M. J. et al. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. <em>Cell Rep. Med.</em><strong>2</strong>, 100466 (2021).
</cite> [<a href="https://doi.org/10.1016/j.xcrm.2021.100466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8714853/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35028608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shapiro,%20A.%20M.%20J.%20et%20al.%20Insulin%20expression%20and%20C-peptide%20in%20type%201%20diabetes%20subjects%20implanted%20with%20stem%20cell-derived%20pancreatic%20endoderm%20cells%20in%20an%20encapsulation%20device.%20Cell%20Rep.%20Med.2,%20100466%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Ramzy, A. et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. <em>Cell Stem Cell</em><strong>28</strong>, 2047–2061.e5 (2021).
</cite> [<a href="https://doi.org/10.1016/j.stem.2021.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34861146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ramzy,%20A.%20et%20al.%20Implanted%20pluripotent%20stem-cell-derived%20pancreatic%20endoderm%20cells%20secrete%20glucose-responsive%20C-peptide%20in%20patients%20with%20type%201%20diabetes.%20Cell%20Stem%20Cell28,%202047%E2%80%932061.e5%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Balboa, D. et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. <em>Nat. Biotechnol.</em><strong>40</strong>, 1042–1055 (2022).
</cite> [<a href="https://doi.org/10.1038/s41587-022-01219-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9287162/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35241836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Balboa,%20D.%20et%20al.%20Functional,%20metabolic%20and%20transcriptional%20maturation%20of%20human%20pancreatic%20islets%20derived%20from%20stem%20cells.%20Nat.%20Biotechnol.40,%201042%E2%80%931055%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Schaeffer, M. et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. <em>Proc. Natl Acad. Sci. USA</em><strong>110</strong>, 1512–1517 (2013).
</cite> [<a href="https://doi.org/10.1073/pnas.1212137110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3557016/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23297228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schaeffer,%20M.%20et%20al.%20Rapid%20sensing%20of%20circulating%20ghrelin%20by%20hypothalamic%20appetite-modifying%20neurons.%20Proc.%20Natl%20Acad.%20Sci.%20USA110,%201512%E2%80%931517%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Buenaventura, T. et al. Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells. <em>PLoS Biol.</em><strong>17</strong>, e3000097 (2019).
</cite> [<a href="https://doi.org/10.1371/journal.pbio.3000097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6716783/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31430273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Buenaventura,%20T.%20et%20al.%20Agonist-induced%20membrane%20nanodomain%20clustering%20drives%20GLP-1%20receptor%20responses%20in%20pancreatic%20beta%20cells.%20PLoS%20Biol.17,%20e3000097%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Sungkaworn, T. et al. Single-molecule imaging reveals receptor–G protein interactions at cell surface hot spots. <em>Nature</em><strong>550</strong>, 543–547 (2017).
</cite> [<a href="https://doi.org/10.1038/nature24264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29045395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sungkaworn,%20T.%20et%20al.%20Single-molecule%20imaging%20reveals%20receptor%E2%80%93G%20protein%20interactions%20at%20cell%20surface%20hot%20spots.%20Nature550,%20543%E2%80%93547%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Roßmann, K. et al. <em>N</em>-Methyl deuterated rhodamines for protein labelling in sensitive fluorescence microscopy. <em>Chem. Sci.</em><strong>13</strong>, 8605–8617 (2022).
</cite> [<a href="https://doi.org/10.1039/d1sc06466e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9337740/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35974762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ro%C3%9Fmann,%20K.%20et%20al.%20N-Methyl%20deuterated%20rhodamines%20for%20protein%20labelling%20in%20sensitive%20fluorescence%20microscopy.%20Chem.%20Sci.13,%208605%E2%80%938617%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>El, K. et al. GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells. <em>Sci. Adv.</em><strong>7</strong>, eabf1948 (2021).
</cite> [<a href="https://doi.org/10.1126/sciadv.abf1948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7954443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33712466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?El,%20K.%20et%20al.%20GIP%20mediates%20the%20incretin%20effect%20and%20glucose%20tolerance%20by%20dual%20actions%20on%20%CE%B1%E2%80%89cells%20and%20%CE%B2%E2%80%89cells.%20Sci.%20Adv.7,%20eabf1948%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Moens, K. et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. <em>Diabetes</em><strong>45</strong>, 257–261 (1996).
</cite> [<a href="https://doi.org/10.2337/diab.45.2.257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8549871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moens,%20K.%20et%20al.%20Expression%20and%20functional%20activity%20of%20glucagon,%20glucagon-like%20peptide%20I,%20and%20glucose-dependent%20insulinotropic%20peptide%20receptors%20in%20rat%20pancreatic%20islet%20cells.%20Diabetes45,%20257%E2%80%93261%20(1996)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>El, K. &amp; Campbell, J. E. The role of GIP in alpha-cells and glucagon secretion. <em>Peptides</em><strong>125</strong>, 170213 (2020).
</cite> [<a href="https://doi.org/10.1016/j.peptides.2019.170213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7580028/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31785304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?El,%20K.%20&amp;%20Campbell,%20J.%20E.%20The%20role%20of%20GIP%20in%20alpha-cells%20and%20glucagon%20secretion.%20Peptides125,%20170213%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Imbernon, M. et al. Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions. <em>Cell Metab.</em><strong>34</strong>, 1054–1063.e7 (2022).
</cite> [<a href="https://doi.org/10.1016/j.cmet.2022.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7613793/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35716660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Imbernon,%20M.%20et%20al.%20Tanycytes%20control%20hypothalamic%20liraglutide%20uptake%20and%20its%20anti-obesity%20actions.%20Cell%20Metab.34,%201054%E2%80%931063.e7%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Anton, S. E. et al. Receptor-associated independent cAMP nanodomains mediate spatiotemporal specificity of GPCR signaling. <em>Cell</em><strong>185</strong>, 1130–1142.e11 (2022).
</cite> [<a href="https://doi.org/10.1016/j.cell.2022.02.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35294858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Anton,%20S.%20E.%20et%20al.%20Receptor-associated%20independent%20cAMP%20nanodomains%20mediate%20spatiotemporal%20specificity%20of%20GPCR%20signaling.%20Cell185,%201130%E2%80%931142.e11%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>McLean, B. A. et al. Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation. <em>Endocr. Rev.</em><strong>42</strong>, 101–132 (2021).
</cite> [<a href="https://doi.org/10.1210/endrev/bnaa032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7958144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33320179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McLean,%20B.%20A.%20et%20al.%20Revisiting%20the%20complexity%20of%20GLP-1%20action%20from%20sites%20of%20synthesis%20to%20receptor%20activation.%20Endocr.%20Rev.42,%20101%E2%80%93132%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Smith, Eric P. et al. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs. <em>Cell Metab.</em><strong>19</strong>, 1050–1057 (2014).
</cite> [<a href="https://doi.org/10.1016/j.cmet.2014.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4109713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24836562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smith,%20Eric%20P.%20et%20al.%20The%20role%20of%20%CE%B2%E2%80%89cell%20glucagon-like%20peptide-1%20signaling%20in%20glucose%20regulation%20and%20response%20to%20diabetes%20drugs.%20Cell%20Metab.19,%201050%E2%80%931057%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Nguyen, K. P., O’Neal, T. J., Bolonduro, O. A., White, E. &amp; Kravitz, A. V. Feeding experimentation device (FED): a flexible open-source device for measuring feeding behavior. <em>J. Neurosci. Methods</em><strong>267</strong>, 108–114 (2016).
</cite> [<a href="https://doi.org/10.1016/j.jneumeth.2016.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4884551/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27060385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nguyen,%20K.%20P.,%20O%E2%80%99Neal,%20T.%20J.,%20Bolonduro,%20O.%20A.,%20White,%20E.%20&amp;%20Kravitz,%20A.%20V.%20Feeding%20experimentation%20device%20(FED):%20a%20flexible%20open-source%20device%20for%20measuring%20feeding%20behavior.%20J.%20Neurosci.%20Methods267,%20108%E2%80%93114%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Miyazaki, S., Tashiro, F., Tsuchiya, T., Sasaki, K. &amp; Miyazaki, J.-I. Establishment of a long-term stable β-cell line and its application to analyze the effect of Gcg expression on insulin secretion. <em>Sci. Rep.</em><strong>11</strong>, 477 (2021).
</cite> [<a href="https://doi.org/10.1038/s41598-020-79992-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7804151/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33436850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miyazaki,%20S.,%20Tashiro,%20F.,%20Tsuchiya,%20T.,%20Sasaki,%20K.%20&amp;%20Miyazaki,%20J.-I.%20Establishment%20of%20a%20long-term%20stable%20%CE%B2-cell%20line%20and%20its%20application%20to%20analyze%20the%20effect%20of%20Gcg%20expression%20on%20insulin%20secretion.%20Sci.%20Rep.11,%20477%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Rezania, A. et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. <em>Nat. Biotechnol.</em><strong>32</strong>, 1121–1133 (2014).
</cite> [<a href="https://doi.org/10.1038/nbt.3033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25211370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rezania,%20A.%20et%20al.%20Reversal%20of%20diabetes%20with%20insulin-producing%20cells%20derived%20in%20vitro%20from%20human%20pluripotent%20stem%20cells.%20Nat.%20Biotechnol.32,%201121%E2%80%931133%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Ester, M., Kriegel, H.-P., Sander, J. &amp; Xu, X. A density-based algorithm for discovering clusters in large spatial databases with noise. In <em>KDD’96: Proc. 2nd Int. Conf. Knowledge Discovery and Data Mining</em> (eds Simoudis, E. et al.) 226–231 (AAAI Press, 1996).</cite>
</li>
<li id="CR51">
<span class="label">51.</span><cite>Ershov, D. et al. TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines. <em>Nat. Methods</em><strong>19</strong>, 829–832 (2022).
</cite> [<a href="https://doi.org/10.1038/s41592-022-01507-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35654950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ershov,%20D.%20et%20al.%20TrackMate%207:%20integrating%20state-of-the-art%20segmentation%20algorithms%20into%20tracking%20pipelines.%20Nat.%20Methods19,%20829%E2%80%93832%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Gavet, O. &amp; Pines, J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. <em>Dev. Cell</em><strong>18</strong>, 533–543 (2010).
</cite> [<a href="https://doi.org/10.1016/j.devcel.2010.02.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3325599/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20412769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gavet,%20O.%20&amp;%20Pines,%20J.%20Progressive%20activation%20of%20CyclinB1-Cdk1%20coordinates%20entry%20to%20mitosis.%20Dev.%20Cell18,%20533%E2%80%93543%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Viloria, K. et al. Vitamin-D-binding protein contributes to the maintenance of α cell function and glucagon secretion. <em>Cell Rep.</em><strong>31</strong>, 107761 (2020).
</cite> [<a href="https://doi.org/10.1016/j.celrep.2020.107761" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7302426/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32553153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Viloria,%20K.%20et%20al.%20Vitamin-D-binding%20protein%20contributes%20to%20the%20maintenance%20of%20%CE%B1%E2%80%89cell%20function%20and%20glucagon%20secretion.%20Cell%20Rep.31,%20107761%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Tarhan, L. et al. Single cell portal: an interactive home for single-cell genomics data. Preprint at 10.1101/2023.07.13.548886 (2023).</cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link"><span>Supplementary Information</span></a><sup> (978.5KB, pdf) </sup><p>Supplementary Figs. 1 and 2, Supplementary Tables 1–5, Supplementary Note 1</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting Summary</a><sup> (2.8MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM3_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Supplementary Data 1</span></a><sup> (19.6KB, xlsx) </sup><p>Statistical Source Data for Supplementary Fig. 2</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Fig. 1</span></a><sup> (48.7KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM5_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Fig. 2</span></a><sup> (27.9KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM6_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Fig. 4</span></a><sup> (25.5KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM7_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Extended Data Fig./Table 1</span></a><sup> (12.7KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM8_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Extended Data Fig./Table 2</span></a><sup> (579.6KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material9_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373499/bin/42255_2025_1342_MOESM9_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link"><span>Source Data Extended Data Fig./Table 3</span></a><sup> (31.2KB, xlsx) </sup><p>Statistical Source Data</p>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Datasets generated and/or analysed during the current study are available from the corresponding authors upon request. Owing to their large size, individual raw image files are available upon request. daLUXendins are subject to a Material Transfer Agreement and the ability to manufacture and supply. All requests for reagents and data will be handled by J.B. or D.J.H., who will respond within 30 working days. <a href="#Sec38" class="usa-link">Source data</a> are provided with this paper.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Nature Metabolism are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s42255-025-01342-6"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/42255_2025_Article_1342.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (13.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373499/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373499/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373499%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373499/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373499/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373499/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830598/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373499/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830598/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373499/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373499/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="cXMzPD3RvWfkc7IhdSVsY6AOKQRg9UIqrv3aYKvXalofJJVbu45NgTcLP2j8RYP4">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
